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Abdulrahman M Jabour 
CANCER REPORTING: TIMELINESS ANALYSIS AND PROCESS 
REENGINEERING 
 
Introduction: Cancer registries collect tumor-related data to monitor incident 
rates and support population-based research. A common concern with using population-
based registry data for research is reporting timeliness. Data timeliness have been 
recognized as an important data characteristic by both the Centers for Disease Control 
and Prevention (CDC) and the Institute of Medicine (IOM). Yet, few recent studies in the 
United States (U.S.) have systemically measured timeliness.  
 
The goal of this research is to evaluate the quality of cancer data and examine 
methods by which the reporting process can be improved. The study aims are: 1- evaluate 
the timeliness of cancer cases at the Indiana State Department of Health (ISDH) Cancer 
Registry, 2- identify the perceived barriers and facilitators to timely reporting, and 3- 
reengineer the current reporting process to improve turnaround time.  
 
Method: For Aim 1: Using the ISDH dataset from 2000 to 2009, we evaluated 
the reporting timeliness and subtask within the process cycle. For Aim 2: Certified cancer 
registrars reporting for ISDH were invited to a semi-structured interview. The interviews 
were recorded and qualitatively analyzed. For Aim 3: We designed a reengineered 
workflow to minimize the reporting timeliness and tested it using simulation.  
 
 vi 
Result: The results show variation in the mean reporting time, which ranged from 
426 days in 2003 to 252 days in 2009. The barriers identified were categorized into six 
themes and the most common barrier was accessing medical records at external facilities.  
 
We also found that cases reside for a few months in the local hospital database 
while waiting for treatment data to become available. The recommended workflow 
focused on leveraging a health information exchange for data access and adding a 
notification system to inform registrars when new treatments are available.  
 
 
Josette Jones, PhD, RN, Chair 
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 INTRODUCTION  CHAPTER 1:
 
1.1 Introduction. 
 
Data are generated, captured, stored, shared, and managed by people, 
organizations, and systems that are in pursuit of information, knowledge, and wisdom. 
Data are considered to be of high quality if they are a fit for their intended use by data 
consumers (Wang & Strong, 1996). Data quality (DQ), a sub-discipline within the 
broader fields of computer science and informatics, is concerned with the study and 
evaluation of the quality of data. The discipline defines the concept of DQ as a complex 
construct that is composed of multiple dimensions. Some of the dimensions that are 
frequently discussed with respect to health data include accessibility, accuracy, 
completeness, and timeliness (Weiskopf & Weng, 2013). 
 
DQ is essential for the efficiency and effectiveness of healthcare organizations. 
The quality of data that are used for evaluating and monitoring population health 
underlies the quality of decision-making processes that rely upon those data. For 
example, cancer registry data are used to guide planning and evaluation programs for 
cancer prevention. This includes the assessment of prevention, screening, and treatment 
programs that guide decisions for health resource allocation (ACS, 2014). 
 
A dimension of DQ that is commonly examined and is important for the 
evaluation and assessment of cancer registries and programs is timeliness—the quality of 
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arriving or being ready on time (e.g., when consumers desire or need data). The 
importance of collecting timely data is well documented in the Institute of Medicine 
(IOM) and the Centers for Disease Control and Prevention (CDC) reports (Centers for 
Disease Control and Prevention, 1999; Simone & Hewitt, 2000).  
 
Timeliness standards used to maintain and monitor reporting are applied at the 
state and national levels. For example, at the state level, the Indiana State Department of 
Health (ISDH) requires health facilities to report cancer cases regularly at different 
frequencies based on the average number of cases diagnosed annually (Table 1-1) 
(ISDH). Currently, hospitals with an average of 1 to 59 cases annually are required to 
report their cases once each year, while hospitals with an average of 300 or more cases 
annually are required to report them on a monthly basis (ISDH). As is the practice with 
most cancer registries, records in the ISDH Cancer Registry are reported from different 
sources using different intervals.  
 
Annual caseload Frequency of reporting 
1-59 Once per year 
60-149 Quarterly 
150-299 Every other month 
300 and more Every month 
Table 1-1: Reporting requirement based on facility caseload. 
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Adopted from: Policy and Procedure Manuals for Reporting Facilities. Indiana State 
Department of Health Cancer Registry. May 2015.  
 
As with most evaluation programs, establishing an objective standard for 
timeliness in measurement is fundamental. At the national level, timeliness requirements 
vary. As seen in (Table 1-2), while the Surveillance, Epidemiology, and End Results 
(SEER) program requires 98% of cases to be reported within 22 months, the Centers for 
Disease Control and Prevention, National Program of Cancer Registries (CDC/NPCR) 
require 95% of cases be reported within 24 months. Other registries, such as the North 
American Association of Central Cancer Registries (NAACCR), require 95% of cases be 
reported within 23 months from the date of diagnosis for Gold Certification and 90% for 
Silver Certification. Therefore, to meet the SEER requirements, both reporting hospitals 
and state registries should take fewer than 23 months to report. Because they are part of a 
larger system, state registries need to meet the international standards of registries, such 
as SEER, CDC/NPCR, and NAACCR. Currently, the ISDH Cancer Registry participates 
in the CDC/NPCR and the NAACCR programs. Since the ISDH Cancer Registry is not 
part of the SEER program, meeting its standard is not required. 
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Standard Percentage of cases required within: 
 12 months 22 months 23 months 24 months 
CDC/NPCR 90%  90% 95% 
NAACCR Silver   90%  
NAACCR Gold   95%  
SEER  98%   
Table 1-2: National requirements for cancer registries.  
 
Adopted from: NPCR Education and Training Series (NETS) Module 3: Quality Control 
for Central Registries. By Scientific Applications International Corporation (SAIC), 
CDC/NPCR. 
 
1.2 Problem Statement 
 
Timely reporting of cancer data is an important aspect of cancer surveillance, care 
delivery, and research (Simone & Hewitt, 2000). Unfortunately, studies have shown that 
reporting delays can, in some instances, take up to 5 years (Boscoe, 2014; Clegg, Feuer, 
Midthune, Fay, & Hankey, 2002). Avoiding delays in reporting plays a critical role in the 
accuracy of cancer incidence rates and the availability of data for cancer research. Longer 
delays in reporting make monitoring trends of cancer cases more difficult (Midthune, 
Fay, Clegg, & Feuer, 2005). Delays in reporting can lead to underestimations of cancer 
incidence rates by causing inaccurate decline signals (INDH; Smith-Gagen, Cress, Drake, 
Felter, & Beaumont, 2005). False decline signals can be observed with incomplete data 
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for recent years compared with complete data from prior years (Midthune et al., 2005). 
With cancer care delivery, reporting delays also hinder timely intervention, as most 
intervention programs are data-driven. Likewise, reporting delays can prevent access to 
recent data that is necessary for research. Assessments of prevention, screening, and 
treatment programs are more valuable if they are presented in a timely manner (Meyer, 
Carpenter, Abernethy, Stürmer, & Kosorok, 2012). 
 
Local hospitals and treating facilities often collect and store data in local 
registries, and subsequently report them to state registries. State registries report cancer 
cases to larger registries, including SEER, NAACCR, and the CDC/NPCR. The process 
of reporting from one registry to another may lead to delays in final data reporting. As a 
result, timeliness remains a central, prevalent issue in accessing and using cancer registry 
data.  
  
1.3 Gap in Knowledge 
 
Several IOM and CDC reports have called for improving the timeliness of cancer 
case reporting; however, the issue has rarely been investigated (Centers for Disease 
Control and Prevention, 1999; Simone & Hewitt, 2000). While a handful of studies in 
Europe have evaluated the timeliness of cancer registry data, their findings are not 
relevant, as the U.S. has established its own cancer registry standards. Within the U.S., a 
study by Gagen and Cress (2005) investigated the factors associated with delays in 
reporting by examining the association between reporting delays and gender, race, type of 
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facility, cancer site, and/or stage at diagnosis (Smith-Gagen et al., 2005). The study 
reported that timeliness varies between reporting facilities and that geographical region 
and facility type (e.g., hospitals, laboratories, or the physician’s office) have the greatest 
impact on timeliness.  
 
To our knowledge, all previous studies investigated timeliness from a DQ 
perspective. None of these studies has investigated the reporting process or the complex 
series of steps that are involved in the reporting process from the time when the cancer 
case is first identified until the state cancer registry certifies it is complete. The purpose 
of this study is to evaluate timeliness as well as the detailed processes that are involved in 
cancer case reporting, explore the barriers and facilitators to timely reporting, and re-
engineer the current reporting process for cancer registries. 
 
1.4 Reporting Process 
 
Cancer reporting involves a series of chronological tasks. Completion of each task 
depends on completion of the previous one; delays in completion of one task will result 
in delays in subsequent tasks and will, thus, delay the overall reporting time. Whereas 
previous studies have evaluated the timeliness of cancer reporting by measuring the 
reporting time as a single process from beginning to end, availability of the date and time 
stamp data that can support examination of different stages in the reporting process is 
unknown. Separating the reporting process into multiple steps will provide more detailed 
information about reporting at the state level. A review by Jajosky and Groseclose (2004) 
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showed that surveillance timeliness studies lacked detailed descriptions of reporting 
stages, such as processing and analyzing (Jajosky & Groseclose, 2004). The study also 
emphasized that the collection and assessment of time intervals is a very important part of 
surveillance systems and timeliness assessment (Jajosky & Groseclose, 2004).  
 
Process improvement requires the right information to identify challenges and 
devise ways to overcome them. Understanding the details of the reporting process will 
aid in guiding the future development of cancer reporting technologies by identifying 
gaps and prioritizing needs. In addition to analyzing time intervals of the subtasks 
involved in the reporting process, this study also includes a field interview for a deeper 
understanding of cancer reporting workflows. 
 
Searching for patients’ records can be a complex process. Data is often stored 
within different systems that have varying standards. The timely collection of a 
comprehensive record can be very challenging. Workflow analysis and process 
reengineering techniques are commonly used for optimizing workflow and reducing its 
complexity. Workflow analysis and process reengineering techniques have been applied 
in many healthcare settings, including pharmacies and emergency departments (Bertolini, 
Bevilacqua, Ciarapica, & Giacchetta, 2011; Chou et al., 2012; Leu & Huang, 2011). 
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1.5 Aims 
 
The goal of this research is to evaluate the quality of cancer data with respect to 
timeliness and examine methods by which the reporting process can be improved. The 
study has the following aims: 
 
 Aim 1: Evaluate the timeliness of cancer reporting at the Indiana State Department 
of Health (ISDH) Cancer Registry. 
 
Several studies have demonstrated the lengthy time period facilities have taken to 
report cancer cases to state registries (ISDH, 2015; Izquierdo & Schoenbach, 2000; 
Midthune et al., 2005). However, states vary in their reporting performance. Currently, 
the timeliness of cancer reporting in Indiana is unknown. Evaluating the timeliness of 
ISDH Cancer Registry data will inform its users regarding the quality of data and how 
this data compares to other national standards. The comparison may include the 
following programs: SEER, NAACCR, and CDC/NPCR.  
 
 Aim 2: Identify the perceived barriers and facilitators to timely reporting. 
 
Despite the magnitude of the problem, barriers and facilitators to timely reporting 
have rarely undergone systematic investigation. This study will explore the tasks that are 
involved in the cancer reporting workflow, as well as barriers and facilitators that are 
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involved with each task. Knowing the barriers and facilitators is important for analyzing 
and identifying potential solutions.  
 
 Aim 3: Reengineer the current reporting process to improve timeliness.  
 
The information from Aim 2 will be employed to inform process reengineering in 
Aim 3. The goal of reengineering the reporting process is to design an alternative 
reporting method that minimizes delay. Accomplishing Aim 3 will include the following: 
• Model the current workflow and identify tasks that generate the most delays in the 
reporting process. 
• Identify tasks within the reporting process that can be modified to optimize 
reporting time. 
• Propose alternative reporting processes and compare them with the current 
process using workflow simulation. 
 
1.6 Study Design Overview 
 
This study was conducted using two sources of data: date and timestamp data 
from cancer cases reported to the ISDH Cancer Registry and interviews with cancer 
registrars. Using triangulation techniques provides more insight into the reporting process 
and overcomes some of the limitations that might be found in one of the sources. Using 
the date and time stamps recorded to report cases provides an overview of the reporting 
process at the state level for a long period of time (9 years). The interviews inform the 
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details of the reporting processes and shed light on practices that could not be answered 
through analysis of temporal data, alone. Having a comprehensive understanding enables 
redesigning of the reporting process to optimize timeliness. Following the construction of 
an alternative workflow, we performed a simulation study to compare the alternative 
process with the existing one.  
 
1.6.1 Timeliness analysis 
 
Examination of the delay in reporting is conducted by analyzing the timestamps 
of cancer cases reported in the ISDH Cancer Registry. Overall timeliness is calculated by 
measuring the number of days from the date of diagnosis to the date when the data 
becomes available for reporting by the registry. In addition to the overall timeliness 
assessment, the study analyzes the dates and timestamps that are associated with different 
phases within the reporting process. This includes comparing the time taken by the 
reporting facility to abstract the case report and send it to the registry, to the time taken 
by the cancer registry to process the report and upload it to their database (Figure 1-1). 
Tasks within the facility reporting process are also examined. These tasks include the 
time taken to initiate the abstract, complete the case report, and export and send reports to 
the registry (Figure 1-1). 
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Figure 1-1: Detailed view of the reporting process with key dates associated with 
different stages within the reporting process. 
 
1.6.2 Interview and field observation 
 
To explore the reporting workflow, cancer registrars from major hospitals within 
Indiana were interviewed. The goal of the interviews was to understand the workflow and 
barriers encountered during reporting. The interviews were in-depth, semi-structured, and 
task-oriented (Appendix 6.1). The interviews were recorded and later transcribed. 
Throughout each interview, the researcher collected the information needed to develop 
the process model, analyze the workflow, and simulate the process. 
 
The information collected at the interview was analyzed at two stages: thematic 
analysis and workflow modeling. The thematic analysis was conducted based upon 
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grounded theory, wherein empirical observations were derived directly from data in order 
to explain barriers and facilitators to timeliness. The key ideas were coded and classified.  
 
The workflow model was then developed to describe the stage of the process 
delays. Re-engineering principles and methods were then applied to identify non-value-
added activities and develop a new way to construct the process (Davenport, 2013; 
Hammer, 1990).  
 
1.6.3 Simulation 
 
This study also simulated the current process to offer insights into its capacity and 
performance. After development of the new process, simulation was employed to 
compare the generated process with the existing process (Curry & Prodan, 2013). The 
simulation modeled the current reporting process as a baseline and compared its 
performance with the suggested process.  
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 LITERTURE REVIEW  CHAPTER 2:
 
2.1 Introduction 
 
The goal of this research was to evaluate the quality of cancer data and examine 
methods for improving the reporting process. In order to accomplish this, we followed 
three steps: measure the timeliness of the cancer registry data, identify barriers within the 
reporting process, and provide recommendations related to process redesign and 
simulation. This chapter will review the previous studies and applications related to these 
main phases. Descriptions of each phase can be seen in the following table: 
 
Phase Goal Theme 
Phase 1: Data 
Timeliness in 
Cancer Registries 
Evaluate the 
current status 
Examine studies related to DQ in cancer 
registries. In this section, a particular focus 
will be on timeliness and methodological 
techniques.  
Phase 2: Workflow 
in Healthcare 
Process 
understanding 
Examine studies related to workflow and 
process redesign in healthcare.  
Phase 3: Simulation 
in Healthcare 
Redesign and 
testing 
Examine studies that use simulation in 
healthcare. 
Table 2-1: Overview of the literature review sections.  
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2.2 Data Timeliness in Cancer Registries 
 
2.2.1 Data quality 
 
Data quality (DQ) has been defined as “the totality of features and characteristics 
of an entity that bears on its ability to satisfy stated and implied needs” (Arts, De Keizer, 
& Scheffer, 2002). In healthcare and public health, the quality of data is important to 
many cases. Incomplete data can, for example, impact health outcomes if patients and 
clinicians do not have all relevant data when making decisions. In public health, 
epidemiologists and medical officers need complete, accurate data when planning 
community-level interventions for cancer prevention. Finally, DQ impacts research, as 
incomplete or inaccurate data will affect the findings of a study.  
 
Cancer registries are important sources of data in cancer-related studies. 
Essentially, registries provide statistics about populations and assist researchers monitor 
trends in cancer cases (Clegg et al., 2002). With respect to cancer, DQ generally needs to 
meet certain standards and expectations for reporting. For instance, the NAACCR sets 
standards and quality attributes for data in cancer registries (2014). 
 
2.2.2 Timeliness 
 
An important factor for ensuring the quality of data is timeliness in reporting. 
Timely reporting supports assessment and quality improvement programs, as well as 
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epidemiological studies, by minimizing turnaround time. Delays in reporting undermine 
the quality of results by underestimating the incidence rate, which results in an inaccurate 
decline signal (Clegg et al., 2002). Longer delays in reporting make monitoring trends in 
cancer cases more difficult (Midthune et al., 2005). Similarly, such delays limit the 
accessibility of timely data required for research. According to the IOM, it is important to 
establish ways of improving the timeliness of cancer data (Simone & Hewitt, 2000). To 
explore ways that timeliness could be examined, we reviewed published studies related to 
timeliness evaluation in cancer registries. The review explored the type of studies, 
evaluation method, and outcome.  
 
2.2.3 Previous studies 
 
Norway conducted a study to evaluate DQ of the Norway Cancer Registry. The 
study evaluated data comparability, completeness, accuracy, and timeliness from 1953–
2005. The timeliness analysis was limited to 2001 and 2005 (Larsen et al., 2009) and 
described timeliness as the “time from diagnosis to registration” and “the time from 
registration to the reporting of incidence via the annual report” (Larsen et al., 2009). The 
study assessed the timeliness of cases diagnosed in 2005 by comparing the number of 
cases reported (published) during November 2006 (one year after diagnosis) and during 
November 2007 (two years after diagnosis); it reported a difference of about 2.2%, 
indicating an underreporting in the one year after diagnosis publication. The study 
reported that the average time taken from diagnosis to registration was 525 days during 
2001 and 261 days in 2005. Given the significant improvement in timeliness reported 
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during the study period, the study predicted greater improvement in the future due to use 
of electronic data reporting (Larsen et al., 2009).  
 
Another DQ study was conducted to evaluate the Icelandic Cancer Registry data. 
The study evaluated data comparability, validity, timeliness, and completeness in 41,994 
cases between 1955–2009. In terms of timeliness, the study examined cases from 2007 to 
2011 (Sigurdardottir et al., 2012). It examined the time taken from the date of diagnosis 
to the time when the data was reported to the registry, and the time taken by the registry 
to process the data and make it available for reporting. During 2007, the facility took an 
average of 238 days to report cases to the registry. However, this time ranged widely 
from 49 to 1,445 days. The study reported that 85% of the cases diagnosed were reported 
to the registry within one year. The study also reported that it would take two years for 
96.9% of the cases to be available in the registry (Sigurdardottir et al., 2012). 
 
Using data from 9 states’ cancer registries within the U.S., Limin and Clegg 
(2002) examined the impact of reporting delays and errors on incidence rates and trends. 
The goal of this study was to develop a statistical model to adjust for reporting delays in 
cancer rates and to predict future corrections, including both additions and deletions 
(Clegg et al., 2002). In this context, the reporting delay was defined as elapsed before a 
diagnosed cancer case was reported to the registry. The standard delay time selected was 
2 years. The study included the following cancer types: female breast, colorectal, 
lung/bronchus, prostate, and melanoma. The study analyzed the reporting of adjusted 
cases from 9 North American states’ cancer registries that participated in the 
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Surveillance, Epidemiology, and End Results (SEER) program from 1981 to 1998. The 
participating states included Connecticut, Hawaii, Iowa, New Mexico, and Utah, and the 
metropolitan areas of Atlanta, Detroit, Seattle-Puget Sound, and San Francisco-Oakland. 
The study measured the delay by calculating the difference in completeness rates during 
each diagnosis year. The delay distribution was considered completed after 19 years 
(Clegg et al., 2002). The study reported that 88% to 97% of the diagnosed cases were 
reported within the first 2 years. The study also reported that it would take 4 to 17 years 
for 99% of the cases to be reported (Clegg et al., 2002). Based on the cancer site, the rate 
of reporting delay could vary widely. Since this study revealed that reporting can take up 
to 17 years, an important factor to consider is the period during which the data is 
evaluated. The study evaluated data from 1981 to 1998, and thus, many changes were 
introduced to the field since that time period, such as increasing the adoption of 
Electronic Health Records (EHR) and the use of Electronic Pathology Reporting Systems 
(E-path).  
 
Gagen and Cress conducted a more recent study in the U.S. in 2005 to examine 
the timeliness of the California Cancer Registry’s data. The goal of the study was to 
explore the factors associated with reporting delays at the population level (Smith-Gagen 
et al., 2005). The study included cases diagnosed between January 1 and December 31, 
2000. The data was retrieved 4 years after diagnosis (August 2004) and included the 
following cancer types: breast, prostate, colorectal, lung, non-Hodgkin’s lymphoma, 
leukemia, melanoma, corpus, bladder, and pancreas (Smith-Gagen et al., 2005). The 
study defined timeliness as the interval between the date of diagnosis and the date the 
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case was available for research at the regional registry. The analysis split timeliness into 
the following 2 parts: the first part was the time from diagnosis to when the case was 
received by the registry, and the second was the time taken at the registry to make the 
data available for research. The analysis examined the variation in timeliness based on 
the following variables: type of reporting source, type of cancer, stage, gender, and age. 
The study applied univariate and multivariable analysis to examine the effects of these 
variables on timeliness (Smith-Gagen et al., 2005).  
 
The study showed that 45% of the diagnosed cases were available at the registry 
within 12 months from the date of diagnosis and 96% were available within 24 months. 
The study showed that the average timeliness was 382 days. This included both the time 
taken by the facility to send the reports and the time taken by the registry to process the 
reports and make data available for research. The average time taken by facilities to send 
the reports was 268 days. This time was slightly shorter among hospitals than non-
hospital facilities. The median number of days taken by the registry to process the cases 
and make them available for research was 69 days; however, this time varied widely, 
ranging from 32 to 208 days. The study also indicated that timeliness varied by 
geographical region, but no significant variation was related to gender, age, or stage of 
cancer (Smith-Gagen et al., 2005).  
 
Tomic and Sandin, et al. (2015) conducted a study in Sweden to assess 
completeness, timeliness, validity, and comparability of the National Prostate Cancer 
Register (NPCR). Both completeness and timeliness were evaluated by cross-linking the 
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2 data sources: Swedish Cancer Register (SCR) and NPCR. The 2 data sources collect 
data differently from the diagnostic pathology department and from the treating clinical 
department. By linking both of these sources, the study compared the date of registration 
and registration status at the NPCR of Sweden with data in the SCR.  
 
The study reported noticeable improvement in timeliness after 2007, which might 
be attributed to the introduction of electronic reporting. In 2008, for instance, 34% of the 
cases were reported within 3 months, 51% within 6 months, and 77% within 12 months. 
In 2012, 45% of the cases were reported within the first 2 months, 76% within 6 months, 
and 95% within 12 months. The study also reported a shorted timespan in NPCR 
compared to the other cancer registries, such as the Nordic National Cancer Registers, 
Icelandic Cancer Register, or Norwegian Cancer Register (Tomic et al., 2015).  
 
2.2.4 Measuring timeliness 
 
When evaluating timeliness, some studies report timeliness as the average number 
of days from the date of diagnosis to the date when data is available for research. This 
includes the sum of both the time taken by the facility to abstract and send the report and 
the time the registry needs to process the report and make it available for publication. 
However, other studies separate these 2 periods to distinguish between the time taken by 
the reporting facilities and the time taken by the registries.   
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Hunt (2004) outlined 2 approaches for timeliness measurement (National Cancer 
Registrars, 2004). The first approach calculates the proportion of cases abstracted in a 
given time of the year, as compared with the number of cases anticipated in that year. 
This percentage is then compared with the amount of time that has elapsed to date in the 
current accession year, minus the allowable reporting timeframe (National Cancer 
Registrars, 2004). The second approach calculates the difference between the date of 
diagnosis and the date of data entry. Some of the common data items employed in this 
approach are date of diagnosis, date of admission or first contact, and date when the 
records are transferred to the registry (National Cancer Registrars, 2004). 
 
2.2.5 Standards, technology, and timeliness 
 
Another factor that could potentially influence the timeliness of states’ registries 
reporting is the standards and regulations of the national registries in which the states 
participate. Most states’ registries are required to report their cases to larger national 
registries, because national registries have certain standards and regulations regarding the 
timeliness of the data received. For instance, SEER requires all cases be reported within 
23 months of the date of diagnosis. While, on the other hand, the CDC/NPCR requires 
90% of cases be reported within 12 months of the date of diagnosis and 95% of the cases 
be reported within 24 months (Larsen et al., 2009).  
 
Other standards, such as those outlined by NAACCR, have different levels of 
certification for state registries. To meet the NAACCR golden certification, states need to 
 21 
report 95% of the cases within 23 months of the date of diagnosis. On the other hand, to 
meet NAACCR silver certification, states need to report 90% of their cases within 23 
months of the date of diagnosis (NAACCR, 2014). 
 
Another factor that could impact reporting timeliness is the use of health 
information technologies. Larsen and Smastuen (2009) reported a 50% improvement in 
the Norway Cancer Registry’s reporting time from 2001 to 2005. The reported 
improvement was attributed to the introduction of electronic data reporting (Larsen et al., 
2009). Tomic and Sandin (2015) reported a similar finding, indicating that an 
improvement in timeliness coincided with the introduction of electronic reporting in 
2007. 
 
2.2.6 Reporting process and timeliness 
 
Cancer reporting involves a series of interdependent tasks. The completion of 
each task depends on completion of the previous one; delays in the completion of one 
task will result in a delay in subsequent tasks and, thus, a delay in the overall reporting 
time.  
 
Often, the data collected by local hospitals and other treating facilities is stored in 
the hospital’s local registry, which is then reported to state registries. After that, state 
registries report to larger registries, including the NAACCR and CDC/NPCR. The 
process of reporting from one registry to another may lead to a delay in final data 
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reporting. Moreover, errors that may exist with certain tasks will be reflected in an 
overall report. Most of the reviewed studies evaluated the timeliness in cancer reporting 
by measuring the reporting time as a single process from the date of diagnosis to the date 
when the data is made available at the registry. Some separated the facility reporting time 
from the registry processing time. However, none of the studies examined the various 
stages of reporting within hospitals. The ability to examine the different stages of the 
process remains unknown. Separating this process into multiple steps will provide more 
detailed information about reporting at the state level. A review conducted by Jajosky and 
Groseclose (2004) reported that surveillance timeliness studies lack detailed descriptions 
of reporting stages, such as processing and analyzing. The study also emphasized that 
collection and assessment time intervals are an important part of surveillance systems and 
timeliness assessment (Jajosky & Groseclose, 2004).  
 
Improving timeliness requires understanding the reporting process. Understanding 
the reporting process can help to identify gaps, prioritize needs, and support the future 
development of cancer reporting technologies. Prior studies lacked details of the 
reporting process and factors that may contribute to lengthy reporting; therefore, the issue 
remains under-investigated. 
 
2.3 Workflow in Healthcare 
 
The Agency for Healthcare Research and Quality (AHRQ) defines workflow as a 
“series of steps performed by different staff members, and often dependent on related 
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workflows, that accomplishes a particular task” (Aggarwal, Backman, Sager, & Sannyasi, 
2010). Given the complexity of each organization, the efficiency of workflow is 
determined by the system as a whole. Like most fields, the use of information technology 
in healthcare is rapidly increasing, and the changes induced by them are improving how 
healthcare organizations function. Adapting to these changes often requires a consistent 
evaluation of process and reengineering to ensure integration of the organization’s 
component parts (Champy & Greenspun, 2014). 
 
Healthcare organizations are complex systems and the integration of 
organizational, human, and technical elements plays a critical role in their success and/or 
failure. The increasing demand for better service and the recent introduction of health 
information technology makes it more important than ever to systemically evaluate and 
analyze an organization’s workflow and redesign it to its full potential. Knowledge from 
different domains, such as design, human-computer interaction, and business 
management, are increasingly applied in healthcare to cope with the rapid change 
induced by health information technology (HealthIT, 2015).  
 
2.3.1 Workflow and process redesign theories 
 
Many theories support workflow and process redesign. Theories like Six-Sigma, 
LEAN, Deming’s Cycle of Continuous Improvement, Total Quality Management (TQM), 
and Business Process Reengineering (BPR), are well known for increasing performance 
and productivity (Aggarwal et al., 2010). Most of these theories were designed for the 
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purpose of enhancing performance; therefore, some put more emphasis on identifying 
inefficiencies within the process, where others are more focused on providing a solution. 
Other workflow and process redesign theories have some differences and similarities in 
how they function and perform.  
 
Overall, most workflow and process redesign theories will include techniques for 
understanding the system being studied, analyze the system, provide an alternative, and 
implement the alternative (Table 2-2). Six-Sigma, for instance, contains the following 5 
steps: define, measure, analyze, improve, and control (Aggarwal et al., 2010). Similar 
approaches can be seen with Deming’s Cycle of Continuous Improvement, which 
contains these 4 steps: plan, do, check, and act (Stankard, 2002). Another example is the 
LEAN system, which involves the following steps: identify the key activities that create 
value, determine the current state, modify the current state by eliminating non-value 
activities, implement changes, and count improvement (Aggarwal et al., 2010).  
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 Six Sigma Deming’s Cycle of 
Continuous 
Improvement 
(Standard, 2002) 
LEAN System 
Step 1 Define: Define the 
problem, project 
goal, stakeholders’ 
requirement. 
Plan: Study the current 
situation. 
Develop theory about 
improvement. 
Design a test of theory. 
Identify the key 
activities that 
create value. 
Step 2 Measure: Develop 
and implement a 
data collection plan. 
Do: Run a test of theory 
on the pilot. 
Determine the 
current state. 
Step 3 Analyze: Analyze 
data. Identify the 
issues within the 
process. 
Check: Study how the 
actual result compare with 
the anticipated results and 
learn. 
Modify the 
current state by 
eliminating the 
non-value 
activities. 
Step 4 Improve: Address 
the issues, and 
eliminate the causes 
of dysfunction.  
Act: Expand the use of 
what worked and 
eliminate what didn’t.  
Implement 
changes. 
Step 5 Control: Control the 
new plan and create 
a future plan. 
 Count 
improvement. 
Table 2-2: Overview process and redesign theories.  
 
As seen in these examples, there are common, fundamental steps that seem 
essential for most workflow improvement activities. Those steps are: 1) information 
gathering, 2) analyzing the information and understanding the existing status, 3) 
redesigning the workflow, and 4) implementing the new workflow. The following section 
will explore these fundamental steps and review some of the applications to perform each 
of them. 
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2.3.2 Information gathering 
 
A study’s purpose and context often determines the design of a workflow study. 
As stated previously, healthcare organizations vary widely from one department to 
another; given this diversity, data collection techniques may also differ. In general, 
assessment studies can generate data by a variety of techniques, such as system-generated 
data, surveys, interviews, and/or observation (Unertl, Novak, Johnson, & Lorenzi, 2010). 
As there is no rule for which approach is ideal, some studies use a combination of 
techniques. Commonly, they take a qualitative empirical approach that seeks 
understanding, rather that confirming a hypothesis. For example, a systematic review 
conducted by Unertl and Novak (2010) found that the majority of workflow studies were 
qualitative (65 citations), as compared to quantitative (13 citations) and the mixed 
approach (35 citations). Their review also concluded that the most frequent technique 
was ethnographic observation (65 citations), followed by interview (58 citations), and 
artifact collection (29 citations) (Unertl et al., 2010). Lastly, their study found that within 
the healthcare setting, the most frequently studied subjects were nurses (51 citations) and 
physicians (45 citations), followed by other healthcare staff, such as administrative staff, 
pharmacists, and laboratory and radiology technicians (25 citations). Where some studies 
used saturation to decide the number of subjects, no further information was given 
regarding the number of subjects or sites studied (Unertl et al., 2010). Most were 
conducted over a period of weeks or months.  
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2.3.3 Workflow analysis 
 
Workflow analysis is key to understanding a process and potential problems. 
Workflow analysis is performed before redesigning or proposing changes. This allows for 
the understanding of workflow to identify the tasks that need to be redesigned. The goal 
of this stage is often to identify what parts need to be redesigned and how critical they 
are. One of the most commonly applied methods of workflow analysis is workflow 
mapping. 
 
Workflow mapping is a diagraming technique performed by creating a graphical 
illustration of the workflow process to determine the big picture and how the different 
elements of the system interact with one another. The goal of this step is to make the 
invisible visible. It clarifies the interaction between tasks and enables designers to 
communicate their ideas with stakeholders. With the introduction of health information 
technologies, workflow mapping has become more popular in health organizations. It 
facilitates an understanding of the changes induced by the system and allows decision 
makers to find ways to adjust the system to the work environment. Organizations, such as 
Healthcare Information and Management Systems Society (HIMSS) and AHRQ, are now 
providing toolkits for EHR workflow analysis and mapping (AHRQ, 2015; HIMSS, 
2015). 
 
The National Learning Consortium (NLC) lists 3 levels of workflow mapping 
based on the level of detail included in the mapping work. Those levels are macro (higher 
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level), mini, and micro (lowest) (National Learning Consortium, 2012). Depending on the 
level of detail and the amount of information collected during the information-gathering 
phase, this step can be very specific, in terms of reflecting every detail of the system 
process, or it can be very abstract, pointing out only the basic elements. Given the 
informal nature of workflow studies, such details are often determined by the study 
purpose and context.  
 
2.3.4 Process redesign 
 
Workflow redesign is often conducted in an informal manner, where the designer 
analyzes the workflow and brainstorms ways to improve the current process. The efficacy 
of this approach depends on the designer’s creativity and experience, as well as the 
domain and field of study. Different backgrounds may emphasize different areas of 
concern and/or they may apply different techniques for redesign. Designers with a 
psychology background, for instance, will have a different perspective from designers 
with an engineering background. A review study by Unertl, el al. (2010) further 
exemplifies this idea. The review included 127 workflow and redesign studies. By 
categorizing studies based on the research perspective, the review showed 14 different 
areas of research, ranging from management, computer science, and health services, to 
anthropology and sociology (Unertl et al., 2010). One of the most advanced fields in 
workflow and process redesign is business and supply chain management. 
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One of the most popular workflow redesign techniques was established by 
Micheal Hammer in 1990; it was known as Business Process Reengineering (BPR) 
(Hammer, 1990). The principles of BPR aim to identify the underlying causes of process 
deficiencies and dysfunctions (Table 2-3).  
 
• Organize around outcome, not tasks. 
• Have those who use the output of the process perform the process. 
• Subsume information processing work into the real work that produces the 
information. 
• Treat geographically dispersed resources as though they were centralized. 
• Link parallel activities instead of integrating their results. 
• Put the decision point where the work is performed. 
• Capture information once and at the source. 
Table 2-3: BPR principles.  
 
These principles are designed to fundamentally change and recreate how 
organizations work, instead of offering minor modifications to fix individual tasks. A key 
advantage of such an approach is that it deals with the system as a whole and considers 
all tasks involved when proposing changes. This allows for more integration between 
system parts and minimizes pitfalls induced by changing one of the system’s elements. 
However, such a big change can be hard to implement. Introducing fundamental change 
can create people resistance and require much effort when dealing with human and 
organizational factors.  
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The LEAN system offers a more subtle approach. With the LEAN system, the 
redesign phase focuses on eliminating waste and identifying non-value-added activities. 
This is performed by evaluating efficiency of the system parts and involves searching for 
unnecessary waste within the process. Such waste could be time or resources (such as 
people, capital, etc.). Since the LEAN technique is more subtle and incremental, the 
changes produced are expected to be closer to the current system status and produce less 
resistance compared to BPR. On the other hand, due to the iterative nature of this 
approach, it may be least prepared to address systemic issues/problems.  
 
2.3.5 Implementation and testing 
 
Introducing a new system can be complicated and difficult. It requires changing 
the way people operate. Managing such change is often costly and time-consuming 
(Fleurant et al., 2012), requiring training staff and collaboration between stockholders 
and IT management (Goroll, Simon, Tripathi, Ascenzo, & Bates, 2009). Dealing with lost 
productivity and unexpected errors are common concerns in system implementation. 
Some of the most-discussed topics include people resistance, system integration, and 
inadequate infrastructure.  
 
Many workflow improvement and process redesign theories suggest a continuing 
cycle of redesign after implementation. The reassessment phase enables refinement and 
optimization of the work process (Unertl et al., 2010). In some cases, simulation software 
is employed to test the proposed process before the implementation phase. This can 
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mimic real-life performance and predict potential issues in a risk-free environment. The 
next section will review some of the simulation applications in healthcare. 
 
2.4 Simulation in Healthcare  
 
Simulations in healthcare are sometimes employed to minimize the shortcomings 
of implementation and detect some potential issues without risking damage to the actual 
process (Borycki, Kushniruk, Kuwata, & Kannry, 2006). Simulation aids in identifying 
disparity between the expected outcome and the observed outcome. Such a disparity can 
be attributed to a variety of reasons, including confounding variables that are rarely 
captured during the information collection process, individual resistance, or unpredictable 
system behavior. This is especially valuable in organizations, including healthcare, where 
intervention can be complex. When considering the probability of compromising safety, 
productivity, or financial gain associated with implementing a new system, a risk-free 
alternative, such as simulation, can be a superior option (Baldwin, Eldabi, & Paul, 2004). 
Although many simulation studies use simulation software for processes testing, some 
utilize it to understand existing ones.  
 
A slightly different approach to applying simulation was suggested by Blandwin 
et al. (2004). The study highlighted the advantages of employing simulation as a 
problem-solving tool, as it can promote a better understanding of the system, thus 
enhancing decisions (Baldwin et al., 2004). Most engineering applications adapted 
simulation for system testing. Given the advancement of simulation use in the 
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engineering field, many healthcare studies have adopted a similar approach by testing the 
potential impact of health information technology in a corresponding environment. 
However, healthcare organizations are structured differently. They often include more 
stakeholders and decision makers, with a high degree of interaction between them. With 
such complexity, making a decision that satisfies all stakeholders can be more 
complicated. Utilizing simulation to illustrate workflow and simplify intricacy can 
highlight understanding the process and identify dysfunctions (Baldwin et al., 2004).  
  
Shared and carefully planned decisions are especially important in healthcare, 
where the outcome of change is critical. A review of the literature where simulation was 
applied in surgical care reported that only 50% of the reviewed content used simulation to 
address the needs of policymakers, whereas 26% included stakeholders, such as health 
system managers and policymakers, in the study (Sobolev, Sanchez, & Vasilakis, 2011). 
An example of this approach is a case study conducted by Bertolini et al. (2011). The 
study applied simulation to improve the process in the surgical department. The study 
applied mapping and simulation to analyze all existing processes. Through simulation, 
the study identified some of the current system’s dysfunctions. The study also 
emphasized the need to overcome the traditional approach in most simulation tests, where 
designers are disconnected from stakeholders. Instead, the stakeholders were described as 
an interactive group that contributed to the process development. The study also reported 
that using simulation contributed to understanding the most efficient management choices 
(Bertolini et al., 2011). 
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2.4.1 Simulation in different healthcare settings 
 
Simulation techniques were used in diverse healthcare settings. A review by 
Gunal and Pidd (2010) reported that the most common healthcare area to apply 
simulation was Accidents and Emergencies (A&E), followed by inpatients facilities. 
Other less common areas included Intensive Care Units (ICU), laboratories, surgical 
units, pharmacies, and screening units (Günal & Pidd, 2010). Another literature review 
focusing on simulation studies for surgical units reported that very few studies have used 
simulation to redesign workflow in this particular setting. The study found only 34 
related publications from 1957 to 2007 (Baldwin et al., 2004).  
 
While the focus of this research is the reporting process of cancer cases, none of 
the conducted studies included the use of simulation to analyze the process of public 
health reporting, such as reporting cancer, infectious disease, or sexually-transmitted 
disease.  
 
2.4.2 Simulation models validation 
 
Simulation validation refers to the process of ensuring the model representative. 
In a situation where simulation is intended to reflect the existing workflow status, 
observing its output can help to ensure the accuracy of the system’s elements. This is 
known as internal validity. On the other hand, external validity ensures that the system’s 
variables represent the real-world process. The variables include subject, setting, case, 
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task, and/or scenario. A system that captures accurate, real-life events and produces 
representative results can describe the behavior of the process being studied. Having a 
system that describes the real-world process can aid in solving workflow problems and 
identify dysfunctions (Borycki et al., 2006).  
 
In a study that used simulation to redesign a pharmacy’s workflow, similar 
validation techniques were applied. After modeling the existing status, the study used the 
system yield to compare it with real-world output as a validation method (Wong, Geiger, 
Derman, Busby, & Carter, 2003). A similar approach was also applied in a simulation 
study of surgery units. The study compared the simulation system output with real-world 
data, which was collected during a 1-year period. The study referred to the observed data 
as the real value of operation and the system-generated value as the predicted value of 
operation (Bertolini et al., 2011).  
 
Another method for validating simulation is using experts or subjects who are 
knowledgeable about the workflow (Unertl et al., 2010). In this technique, experts 
validate that the models’ assumptions are correct. Working with subjects who are familiar 
with workflow will help in identifying issues in the designed conceptual model (Banks, 
1998). 
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2.4.3 Simulation techniques in healthcare 
 
As for the simulation approach, studies reported that Discreet Event Simulation 
(DES) is the most commonly used technique in healthcare studies. DES presents the 
workflow process as a series of chronological activities where each activity is described 
as an event. Each event is associated with characteristics, such as time, to describe 
performance. This allows the model to capture detailed information to represent the real-
life process behavior. These features promote the widespread use of DES in healthcare 
studies. A review by Sobolev, et al. (2011) indicated that around 75% of simulation 
studies identified applied DES. Other approaches included System Dynamic (SD) models 
(9%), the Monte Carlo model (6%), and Makov (3%) (Sobolev et al., 2011).  
 
When comparing DES with other simulation techniques, such as SD, Brailsford 
and Hilton reported that SD lacked the detailed description needed for healthcare 
simulation studies (Brailsford & Hilton, 2001). Studies favor DES for its ability to 
express more details, as well as provide animated and dynamic illustrations to 
communicate findings with clients (Brailsford & Hilton, 2001). 
 
The findings stressed that SD was appropriate for strategic or conceptual level 
uses, but it also reported that SD models were not always simulated. An example would 
be the influence diagrams, which are a useful part in the modeling process. DES referred 
to this as “the technique of choice for modeling healthcare systems, which are 
characterized by variability, uncertainty, and complexity” (Brailsford & Hilton, 2001). 
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2.4.4 Simulation software 
 
In terms of simulation software, review studies showed that Arena simulation 
software was the most commonly used software in healthcare (20%); followed by the 
programming language Borland Delphi (17%); Simul8 (10%); followed lastly by others, 
such as Pascal, AutoMod, and SIGMA (7%) (Sobolev et al., 2011). 
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 METHODS   CHAPTER 3:
 
This study used a mixed-method approach of objective and subjective data. The 
two sources of data were time intervals data associated with previously reported cases 
and interviews. This method consisted of the following parts: data tracking, interview, 
and simulation. Data tracking was used to evaluate the time taken to report previously 
reported cases. The interviews, however, were used to identify challenges to timely 
reporting, while informing workflow and simulation development. Lastly, simulation was 
developed to examine the proposed workflow and compare it to the existing workflow.  
 
3.1 Data Tracking: Context and Data Retrieval  
 
The study was approved by the Institutional Review Board at Indiana University. 
The dataset was retrieved from the ISDH Cancer Registry. The ISDH Cancer Registry 
collects all malignant cancer cases required for reporting by federal regulation or the 
National Program of Cancer Registries (INDH, 2015). The registry contains information 
on cancer cases needed for performing epidemiological, preventive, and control studies. 
It also contains demographic data, tumor-related data, and some treatment information 
(INDH, 2015) from state hospitals, physician clinics, and radiology centers. The cohort of 
this data was patients’ diagnosed with breast, colorectal, or lung cancer from 2001 to 
2010.  
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In total, there were 76,259 de-identified cases chosen from among highly 
prevalent types of cancer: 28,782 breast cancer cases, 19,530 colorectal cancer cases, and 
27,947 lung cancer cases. The variables retrieved for this part of the study were cancer 
type, reporting sources, date of diagnosis, and the date associated with each phase of the 
reporting process.  
 
3.2  Phase 1: Data Tracking - Timeliness Overview 
 
Past studies described timeliness as “the rapidity at which a registry can collect, 
process and report sufficiently reliable and complete cancer data” (Bray & Parkin, 2009). 
When measuring cancer registry data timeliness, prior studies define it as the as “The 
interval between date of diagnosis” and “the date the case was available in the registry for 
research” (Smith-Gagen et al., 2005). Phase 1 focuses on overall timeliness from the time 
of diagnosis to the time when data was made available at the state registry. This includes 
the sum of both the time taken by the facility to abstract and send the report to the state 
registry, and the time taken by the state registry to process the report and make it 
available for external use by researchers and other stakeholders.  
 
Hunt (2004) outlines 2 approaches for timeliness measurement (National Cancer 
Registrars, 2004). The first is to calculate the percentage of the number of cases 
abstracted in a given time of year compared with the expected number of cases in that 
year. This percentage is then compared with the amount of time that has elapsed to date 
in the current accession year, minus the allowable reporting timeframe (National Cancer 
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Registrars, 2004). The second approach is to calculate the difference between the date of 
diagnosis and the date of data entry; some common data items employed in this approach 
are date of diagnosis, date of admission or first contact, and date when the records were 
transferred to the registry (National Cancer Registrars, 2004). The date of first contact 
refers to the date the patient was first seen or admitted to the facility for malignancy 
diagnosis or treatment, whichever is first (North American Association of Central Cancer 
Registries , 2012). In quality control, this date is used with the “date tumor records are 
made available” to measure overall timeliness (North American Association of Central 
Cancer Registries , 2012). “The date of first contact” is also used by the Commission on 
Cancer (CoC) as the starting point to measure abstracting time (Surgeons, 2014). In this 
study, we applied the second approach to the timeliness evaluation. 
 
3.2.1 Analysis 
 
Measuring timeliness was conducted by analyzing the timestamps of previously 
reported cases using the Statistical Package for Social Sciences (SPSS) software version 
21. The analysis measured the number of days from the date of diagnosis to the date 
when data became available for reporting by the registry. The “date of first contact” was 
the starting point and the “date when the report was made available for reporting” was the 
end point.  
 
To calculate the difference between the date of diagnosis and the date when data 
was made available, we needed to have both dates. Out of the 76,259 cases retrieved, 
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8,175 were excluded, because of missing data. The dates of the time intervals were 
recorded in day/month/year format. Cases where any of these values were missing were 
also excluded from the analysis. Cases diagnosed during the last year of the study period 
(2010) were also excluded, due to the low number of cases retrieved (1,066 cases 
compared to an average of 7,377 in previous years).  
 
The data were later checked for data validity. Given the logical meaning of the 
time intervals, the date of diagnosis was expected to be earlier than the date the data was 
made available at the state registry. Cases that did not follow this order were identified as 
invalid data. Invalid data also included outliers at the 0.99% end of the distribution. 
Reporting timeliness was then stratified by type of cancer and year of diagnosis. 
 
Finally, we calculated the mean, median, and percentage of records that met the 
predefined measures for reporting performance. The measures were drawn from the 
timeliness requirements of national registry standards, such as SEER, NAACCR, and 
CDC/NPCR. NAACCR, for instance, requires hospitals to report 95% of cases within 23 
months of the date of diagnosis. In contrast, CDC/PNR allows 12 months for 90% of 
cases to be reported and 24 months for 95% of cases. The SEER registry standard, 
however, requires the total count to be reported to NCI within 22 months (NCI, 2014). 
The length of time used to report performances was 6 months, 12 months, 22 months, 23 
months, and 24 months. 
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To assess consistency in reporting speed, we calculated historical data for the 9-
year period from 2001 to 2010. We calculated the overall annual mean of reporting time, 
as well as the mean for each of the 3 cancer types. The number of cases within each year 
was determined based on the date of diagnosis.  
 
3.3  Phase 2: Data Tracking - Reporting Stages Timeliness 
 
In Phase 1, we evaluated the time needed to report cancer cases to the state 
registry. In this section, we will explore details of the various stages of reporting, provide 
an overview of the fundamental phases of the reporting process, and offer a description of 
the method used to evaluate the various stages of cancer reporting. 
 
3.3.1 Basic Steps of Cancer Reporting 
 
Analyzing time intervals at each phase will require an understanding of the 
reporting process. In this part of the analysis, we will outline the reporting steps 
measured, as well as the time intervals associated with each phase. The cancer reporting 
process involves the following steps. 
 
 Case Finding 
 
Case finding is the process of identifying new cancer patients for a given time 
period. At this step, the list includes cancer records associated with any diagnosis, 
 42 
treatment term, or code, indicating a reportable cancer condition. These lists are often 
defined by registry-approved programs (SEER, 2015). Once a case is reviewed and 
identified as a reportable case, it is added to a suspense file in preparation for abstracting. 
The time from diagnosis to the beginning of abstracting can represent the time from the 
“date of diagnosis” to the “date of abstract initiation” (Figure 1-1). 
 
 Abstracting 
 
Abstracting is the process of collecting and compiling information about each 
reportable patient in preparation for sending the report to the state registry. Abstracts are 
often comprehensive reports that include all the cancer-related information required by 
the receiving registry. The abstract may include data related to demographics, tumor 
information, staging, diagnostic studies, and treatment. Once the abstract is completed, it 
is saved in preparation for reporting. 
 
Reporting facilities, in general, save completed abstracts for purposes of reporting 
them to registries on a fixed schedule. The abstracting time is described as the time 
needed to find the required information, collect it, and then compile it into an abstract. 
Once all the required information is collected and the abstract meets the receiving 
registry’s requirements, the abstract is considered completed and ready for reporting. In 
this study, the abstracting time is represented by the time from “date of abstract 
initiation” to “date report completed by the facility” (Figure 1-1).  
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 Report Submission 
 
Completed abstracts are sent to the state registry when they are due for reporting, 
which is often done at fixed intervals. The state registries require facilities with higher 
caseloads to report at higher frequencies. The time from abstract completion to when the 
state registry receives the report can be calculated by measuring the time from “date 
report completed by the facility” to “date report received by the registry” (Figure 1-1). 
 
 Editing and Processing 
 
State registries receive reports from multiple facilities that may need to be 
checked and edited before they are made accessible to researchers. The registry 
processing time is calculated by measuring the time from “date report received by the 
registry” to “date report available at the registry” (Figure 1-1). 
 
3.3.2 Analysis 
 
As shown in Figure 1-1, the time taken for each phase within the reporting 
process is represented by the difference between the corresponding time interval dates. 
These time intervals indicate the start or end of some stages of reporting. The first part of 
the analysis separates the time taken by the reporting facility from the time taken by the 
registry. Time was measured by number of days using box plots to illustrate distribution 
of the reporting times. 
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Time taken by the facility was then examined by separating the report completion 
time (the time taken for case finding and abstracting) from report submission time (time 
the completed reports remain in the facility database before they are received by the state 
registry). 
 
The “abstract initiation date” (see Figure 1-1) can be used to distinguish case 
finding from abstracting time. However, because of the high rate of missing data in this 
variable, distinguishing these steps was not possible. Instead, we simply measured the 
report completion time. 
 
 Timeliness within Facilities 
 
To examine the variation in reporting time among facilities, we calculated the annual 
average time taken for each individual facility at each stage of reporting. This includes 
report completion time and report submission time by the reporting facilities. 
 
Since the reporting frequency requirements vary based on facilities’ annual 
caseloads, we focused on larger facilities with higher numbers of cases, due to their 
greater impact on the mean. In this section, we included facilities with a total of 1,000 
cases or more for the entire study period, which equals an average of 100 cases per year 
for the 3 cancer types included. 
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Facilities with an average of 60 to 149 cases a year are expected to report their 
cases every quarter. Facilities with higher numbers are expected to report at a higher 
frequency. Facilities included in this part of the analysis are thereby either expected to 
report every quarter, every month, or every other month. 
 
3.3.3 Reporting Frequency 
 
For facilities with a significantly longer report submission time, we performed 
further analysis to evaluate the frequency of reporting, which was assessed by examining 
the distribution of cases reported each quarter. For instance, if a facility reported many 
more cases in one quarter than in others, it is an indication of irregular reporting. 
 
Due to the chronological nature of the cancer reporting process, frequency in 
reporting can be influenced by many factors. A common example is the rate of patient 
visits. When physicians’ offices receive higher numbers of patients in some quarters 
because of the holiday season, more cases will be diagnosed in that season; thus, the 
cases that need to be reported for that season will be higher. Similar effects in the rate of 
reporting might be experienced if patients come for treatment at irregular rates, as some 
treatments are required in order for the abstract to be complete and become ready for 
reporting. Another possibility might be the staffing of registrars who do the reporting. If 
the reporting registrars are part-time or freelance and happen to be overworked during 
particular months of the year, more cases will be reported when they have more free time. 
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To narrow down possibilities, we tracked down the stage when irregularity of 
case distribution started. As seen in the table below, we examined distribution during the 
following 3 phases: time of diagnosis, time of report completion, and time the report was 
received by the state registry (Table 3-1). 
 
Time when irregular 
distribution of cases started 
Potential reasons for irregular distribution of 
cases 
Time of diagnosis More patients visiting the facility and are 
diagnosed during certain quarters. 
Time of report completion More part-time or freelance registrars working 
during particular quarters. 
More patients receive treatments, tests, or 
procedures needed to complete reports during 
certain quarters. 
Submission time or time the 
report is received by the state 
registry 
More completed reports are delivered to the 
registry during certain quarters. 
Table 3-1: Potential reasons for irregular distribution of cases at each phase of reporting. 
 
3.4 Phase 3: Interviews, Barriers, and Workflow 
 
3.4.1  Study Context and Data Collection 
 
This study was approved by the Institutional Review Board (IRB) at Indiana 
University. Cancer registrars reporting to the State of Indiana were invited to participate 
in the interviews, which were conducted either in person or by telephone.  
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Participant selection was based on purposeful sampling that focused on potential 
participants from larger hospitals. The researcher identified participants during hospital 
visits and through the Indiana Cancer Registrars Association (ICRA) directory. Snowball 
sampling—wherein initial contacts identify other individuals who may have insight into 
the topics of interest, e.g., barriers and facilitators to timely cancer reporting—was also 
used. 
 
Potential participants were contacted either by telephone or email. Participants 
were approached until thematic saturation was achieved for a grounded theory analysis. 
Recruitment took place over 5 months, March 22 to August 26, 2015. The average 
interview duration was 28 minutes. Interviews were recorded and later transcribed for 
analysis. At the end of the interview, each participant received a $20 gift card. The final 
interview sample comprised 14 registrars. 
 
Participants were asked to describe the reporting process routine, the steps 
involved, and the estimated time spent on each task. Participants were also asked to 
identify obstacles that affect timeliness of reporting during the process. The interview 
format was semi-structured and task-oriented (Appendix 6.1). 
 
Information from the interviews was used to develop simulations around variables 
such as the average time taken per task and the capacity (both human and capital 
resource) needed for each task. In this context, capacity is described as the number of 
cases that can be performed daily and the time required for each by a registrar. In 
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addition to describing the current state of the cancer registry reporting system, 
interviewees were asked to use a “blue sky” approach to consider optimal cancer 
reporting mechanisms. “Blue sky” thinking transcends concerns about current resources 
or structural limitations. 
 
3.4.2  Analysis 
 
Data collected during the interviews was analyzed in two stages: 1) thematic 
analysis and 2) workflow modeling. For thematic analysis, the transcribed text was 
imported into NVivo 10.2.0 and analyzed. The analysis was based on grounded theory 
and focused on identifying factors that may affect timely reporting and thematic analysis. 
The thematic analysis was derived directly from the data and was used to explain barriers 
to timeliness. The key ideas were identified, then grouped into similar themes.  
 
The main focus of workflow modeling was to develop an alternative reporting 
process to reduce reporting time through process reengineering. The first step was to 
understand and analyze the existing process through a review of current training materials 
that were both related to cancer reporting and directed at cancer registrars, followed by 
interviewing a sample of registrars. In this way, the researcher was familiar with the 
overall process and, therefore, able to explore process details and flaws through the 
interview process. Thus, the researcher was able to notice gaps between policy and 
practice, assess the efficiency of various steps, and document challenges that were 
encountered. During the interviews, registrars were asked to estimate the time spent on 
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each stage of the reporting process. This data was used to model the existing workflow 
and develop a simulation model of the process. Data flow charts were then applied to 
illustrate the complete reporting process.  
 
3.5 Phase 4: Simulation Development and Validation 
 
We simulated the current workflow to demonstrate the time spent per task. The 
simulation was performed using Anylogic 7.1. The simulation provided an indication of 
the time spent at each phase of reporting (e.g., processing time, waiting time, and the time 
cases spent in queue before being processed). The simulation inputs were obtained from 
interviews. During the interviews, participants were asked to estimate the time needed for 
each step in the reporting process. 
 
We then redesigned the reporting process to reduce reporting time and minimize 
some of the barriers identified during the thematic analysis. The redesigned process was 
also simulated to estimate the difference in reporting time compared with the current 
workflow.  
 
The simulation was also validated to ensure an accurate representation of real-
world workflow. The simulation model went through an iterative process of calibration 
and comparison with the existing workflow. Model development occurred concurrently 
with the interviews to investigate model assumptions and enable the iteration process.  
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Model input and output was also compared with reporting time in the real world 
to ensure an accurate representation. After simulating the current workflow, the proposed 
workflow model was simulated and the outputs compared with respect to time. 
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 RESULTS   CHAPTER 4:
 
The purpose of this research was to evaluate the quality of cancer data with 
respect to timeliness and examine methods by which the reporting process can be 
improved. The timeliness evaluation was conducted in 2 phases: overall reporting time 
evaluation and reporting step timeliness evaluation. Timeliness improvement started by 
identifying barriers to timely reporting through interviews. The interview also informed 
the subsequent phases of our study: workflow redesign and simulation development.  
 
4.1 Phase 1: Data Tracking-Timeliness Overview 
 
The initial number of cases retrieved was 76,259; there were 28,782 breast cancer 
cases, 19,530 colorectal cancer cases, and 27,947 lung cancer cases. To calculate the 
difference between the date of diagnosis and the date when the data was made available, 
we needed to have both dates available. Out of the 76,259 cases retrieved, 8,175 were 
excluded because of missing data.  
 
Cases diagnosed during the last year of the study period, 2010, were also 
excluded, due to the low number of cases retrieved (1,066 cases compared to an average 
of 7,377 for previous years). Data cleaning also included removing outliers and invalid 
variables.  
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After cleaning the dataset and excluding cases from 2010, 66,395 cases remained. 
The number of breast, colorectal, and lung cancer cases was 25,013 (37.6%), 17,074 
(25.7%), and 24,308 (36.6%), respectively. The annual number of cases ranged from 
7,083 to 7,726, except for 2009, which had 6,693 cases. 
 
Table 4-1 shows the yearly reporting delay for the 3 cancer types combined. The 
mean for the entire 9-year period was 323.4 days; however, there was a large variation in 
reporting time mean—from 252 to 426 days—across the years. The lowest reporting time 
was 252 days (2009) and the highest 426 days (2003). The reporting time for the rest of 
the data shows less variation: from 292 to 368 days. In some years, the results also show 
a noticeable difference between the mean and median, indicating a skewed distribution of 
data. The difference between the mean and median was highest in 2007 (299 for the mean 
and 220 for the median) and 2008 (313 for the mean and 219 for the median). 
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Year Mean (days) Median 
(days) 
Median-
mean 
difference 
N 
 Breast Colorectal Lung Total    
2001 317.1 315.5 332.4 322.08 292 30 7566 
2002 296.24 280.11 296.32 292 279 13 7702 
2003 427.2 427.2 424 426.05 424 2 7571 
2004 364.59 364.86 374.14 368.19 335 33 7208 
2005 338.68 323.28 337.14 334.08 273 61 7083 
2006 300.5 295.87 309.79 302.79 237 11 7553 
2007 295.84 290.26 310.3 299.83 220 79 7293 
2008 298.28 303.4 334.93 313.35 219 94 7726 
2009 237.72 246.22 273.79 252.88 203 49 6693 
Table 4-1: The average timeliness for each cancer type. 
 
As for stability in timeliness, the results show inconsistency across the 10-year 
period. The average timeliness declined from 2001 to 2002 and then increased by about 
46% (from 292 days in 2002 to 426 days in 2003; Figure 4-1). This was followed by a 
gradual decline until 2009. The graph also shows a similar trend for the 3 types of cancer: 
breast, colorectal, and lung.  
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Figure 4-1: Timeliness for different cancer types from 2001 to 2009. 
 
Figure 4-2: Average overall timeliness from 2001 to 2009. 
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  2001 2002 2003 2004 2005 2006 2007 2008 2009 Mean  
6 
month 
11.9
% 
16.5
% 
03.9
% 
10.8
% 
15.1
% 
19.6
% 
21.1
% 
23.0
% 
37.2
% 
17.68
% 
12 
month 
71.4
% 
82.1
% 
34.4
% 
59.2
% 
68.8
% 
76.6
% 
74.7
% 
70.6
% 
82.6
% 
68.93
% 
18 
month 
92.3
% 
95.7
% 
82.6
% 
87.2
% 
88.7
% 
92.0
% 
88.2
% 
84.6
% 
93.8
% 
89.45
% 
22 
month 
97.1
% 
98.3
% 
93.7
% 
93.3
% 
94.3
% 
94.2
% 
95.3
% 
92.9
% 
97.5
% 
95.18
% 
23 
month 
97.6
% 
98.5
% 
95.0
% 
94.1
% 
95.3
% 
94.7
% 
96.0
% 
94.5
% 
97.8
% 
95.94
% 
24 
month 
98.1
% 
98.8
% 
95.8
% 
94.8
% 
95.7
% 
95.3
% 
96.6
% 
95.9
% 
98.2
% 
96.58
% 
Table 4- 2: Percentage of cases reported within each time period. 
 
For the entire 9-year period, the results show that an average of 17.6 cases was 
reported within the first 6 months, 68.9% were reported within the first 12 months, and 
89.4% were reported within the first 18 months (Table 4-2). The highest percentage of 
cases reported within the first 6 months was 37.2 % (2009) and the lowest was 3.9 % 
(2003). For the remaining years, the percentage of cases reported within the first 6 
months ranged from 10.8% to 23% (Table 4-2). 
 
The percentage of cases reported within the first 12 months was also highest in 
2009, with 82.6%, and lowest in 2003 with 34.4%. For the remaining years, this 
percentage ranged from approximately 60% to 75%. Cases reported within the first 18 
months were also lower during 2003, with 82.6 %, but the highest was during 2002, with 
95.7% (Table 4-2). Over the whole dataset, the average percentage of cases reported 
within 22, 23, and 24 months ranged from 95.1% to 96.5%. Cases reported within the 
first 22, 23, and 24 months were highest in 2002, with 98.3%, 98.5%, and 98.8%, 
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respectively. As for the percentage of cases reported within the first 22 and 23 months, 
both were lowest in 2010, with 92.2% and 93.6%. However, cases reported within the 
first 24 months were lowest in 2004, with 94.8% (Table 4-2). 
 
4.2 Phase 2: Data Tracking-Reporting Stages Evaluation 
 
4.2.1 Reporting Stages 
 
As previously discussed, the reporting process comprises 4 steps: case finding, 
abstracting, report submission, and report processing (Figure 1-1). The first 2 steps, case 
finding and abstracting, were performed at the reporting facility. The completed cases 
then resided at the facility database before being submitted to the central registry for 
processing.  
 
The results distinguished between the time taken by facilities to complete and 
send reports, and the time taken by the state registry to process the cases received. The 
reporting time taken by the facility to complete and send the report for each year is shown 
in Figure 4-3. A higher variation in median reporting time was observed for the period 
2001 to 2005, followed by a more consistent trend for the remaining period of 2006 to 
2010. 
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For most years, there was a large variability in reporting time between cases. 
Variability was higher in 2008 and 2009, especially at the upper whisker. The annual 
number of cases for the observed time period ranged from 7,270 to 7,812. 
 
 
Figure 4-3: Box plot showing the distribution of time taken by facilities to complete and 
submit reports. 
 
The time taken by the state registry to process and edit cases was much lower 
compared to the time taken by the reporting facilities (see Figures 4-3 and 4-4). The time 
taken by the state registry was higher during the first 2 years, 2002 and 2003, with 
medians of around 30 and 20 days, respectively. A noticeable reduction in processing 
time was observed in 2004 and beyond. The processing time was much lower during the 
last 6 years, 2006 to 2010. 
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Figure 4-4: Box plot showing the distribution of time taken by the central registry to 
process received reports. 
 
Time taken by the reporting facilities was further investigated, which revealed the 
difference between the time needed to complete the reports and the time taken to send the 
reports after completion. The median report completion time was highest during 2003 
and 2004, as shown in Figure 4-5. The median reporting time was also more consistent 
during the last 5 years, from 2006 to 2010. Moreover, a noticeable reduction in variability 
in case reporting time was observed starting in 2006. 
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Figure 4-5: Box plot showing the distribution of time taken by facilities to complete 
reports. 
 
Report submission time represents the time taken from report completion to 
receipt by the state registry. With the exception of 2003, the median time was around 50 
days or less for the entire 10 years (see Figure 4-6). The box plots show that the data was 
skewed toward the lower limit with longer upper whiskers. Though most cases (75th 
percentile) took fewer than 120 days, some cases in the upper whiskers took up to a year. 
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Figure 4-6: Box plot showing the distribution of time taken by facilities to submit 
completed reports. 
 
4.2.2 Variation between Facilities 
 
The reports retrieved for the entire 10-year study period were reported from 49 
unique facilities. Of the 49 facilities, 22 were classified as higher-load facilities. The 22 
facilities selected accounted for 90.5% of the cases. The remaining 9.5% came from the 
other 27 smaller facilities. 
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Figure 4-7 shows the average time taken to complete and submit reports at higher-load 
facilities. There was a considerable difference among facilities in average reporting time 
(Figure 4-7); whereas, most facilities took around 200 to 300 days to report their cases, 
others exceeded 400 days. 
 
 
Figure 4-7: Average time taken to complete and submit reports at higher-load facilities. 
 
Facility reporting time was further investigated by distinguishing report 
completion time from report submission time. The time taken to complete reports varied 
among facilities (see Figure 4-8); whereas, most facilities’ reported completion time 
ranged from around 175 to 225 days, a few exceeded 300 days. 
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Figure 4-8: Reported completion times at higher load facilities. 
 
Report submission time is presented in Figure 4-9. A significant difference among 
facilities was found in report submission time; whereas most facilities took less than 50 
days on average to send completed reports to the state registry, 7 of the 22 facilities took 
more than twice that time (around 100 to 300 days). Facility numbers 1, 6, 11, 12, 19, 20, 
and 21 took 106, 274, 325, 172, 256, 155, and 123 days, respectively. 
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Figure 4-9: Report submission times at higher load facilities. 
 
To investigate report submission times for these facilities, we examined the 
frequency of reporting. Figures A-1 to A-7 in Appendix 6-2 illustrate the annual number 
and quarterly distribution of cases received by the state registry from each facility. All 7 
facilities showed an inconsistency in the annual number of reports received by the state 
registry. Higher inconsistencies were observed in facility numbers 1, 12, and 19. 
 
As for quarterly distribution, most facilities showed significant irregularities in 
the number of cases received each quarter in a given year. This irregularity was higher in 
facility numbers 6, 11, and 20. In many years, facilities were submitting all of their 
reports during only 1 or 2 quarters. 
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Since distribution of reports at the report submission phase might have been 
inherited from one or more of the preceding phases, we also investigated the distribution 
of reports in terms of when they were completed and when the cases were diagnosed. 
 
The distribution of cases diagnosed and reports completed is illustrated in Figures 
B-1 to C-7 in Appendix 6-2. The results show that some facilities experienced 
inconsistency in the number of cases diagnosed annually (see Figures C-1 to C-7 in 
Appendix 6-2). The greatest inconsistency was observed in facilities 1, 6, and 12. The 
quarterly distribution of cases diagnosed within the same year was nearly equally 
distributed among all 6 facilities. In facility 1, however, slightly fewer cases were 
diagnosed in the third quarter of 2005 and 2007, respectively. 
 
At the report completion phase, results show that the distribution of reports 
completed each quarter within the same year was nearly equally distributed. Some 
irregularity was observed in a few years, when the number of reports completed in a 
given quarter was relatively smaller than the rest. However, compared to the quarterly 
distribution during the report submission phase, the reports appeared to be completed at a 
more regular frequency. 
 
When comparing the quarterly distribution of the 3 phases (date of diagnosis, date 
of report completion, and date the reports were received by the registry), we find that 
most of the irregularity originated in the last phase, the time between report completion 
and receipt at the registry. This suggests that the increased submission time was not a 
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result of patient visit time or staffing issues, but rather, a workflow issue regarding when 
the completed reports were sent to the state registry. 
 
4.3 Phase 3: Reporting Workflow and Barriers to Timely Reporting 
 
4.3.1 Workflow Description 
 
The developed data flow chart comprises the 3 major steps: case finding, 
abstracting, and report submission (Figure 4-10). The details of each step are described 
below.  
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Figure 4-10: Cancer reporting flow chart (existing status). 
 
 Case Finding  
 
Case finding is the process of finding new cancer cases diagnosed within a given 
time period; it is the first step in the cancer reporting system. It applies to all patients—
inpatients and outpatients—as long as they are diagnosed and/or treated with a reportable 
tumor.  
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Registrars use several data sources for case findings. Most cases, 90–95%, are 
identified through pathology reports. Pathology reports are also useful, because they 
contain detailed information about the cancer (such as diagnosis, histology, and 
behavior). Some facilities use additional sources for case finding, such as hospital 
admission and discharge records, surgery schedules, cytology reports, oncology reports 
(nuclear and medical), radiology reports, and financial billing records. These sources, 
however, are less informative than pathology reports, and registrars often use multiple 
sources or refer to medical records to find the information they need.  
 
Once a case is confirmed as reportable, it is added to a suspense file to await 
abstraction. In most facilities, case finding is performed weekly or monthly, but cases 
may reside in the suspense file for up to 6 months before abstraction. The rationale for 
this is to wait for tests and treatments to be performed and added to the EHR. 
 
 Abstracting 
 
While case finding generally provides an overview of the case, itself, abstracting 
is more comprehensive and detailed. Abstracting uses different parts of medical records 
to collect demographic information, tumor-related information, and information about 
staging, diagnostic studies, and treatment. In general, abstracting is less structured than 
case finding, because registrars use different forms and notes to create a summary. 
Depending on the cancer type and stage, as well as the abstracting registrar’s knowledge 
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and experience, registrars often have an understanding of what treatment paths patients 
are likely to follow and, therefore, they will search records accordingly. 
 
Some registrars indicate that physician notes or discharge summaries can serve as 
a starting point to help them form an overview of the patient journey and guide patients 
as they navigate through sources within medical records. Unfortunately, notes and 
discharge summaries may not become available until long after a patient’s diagnosis.  
 
Interviews show that a patient’s data is not always available in local medical 
records. This happens when patients receive care at different hospitals/facilities. The 
interviews also show that registrars use different methods to access records at external 
facilities, and that the methods vary among registrars. In some cases, registrars contact 
health professionals at the external facility to ask for patients’ records. This was found to 
be easier when most patients are referred to a particular facility, thereby, enabling 
registrars to explain the need for collecting patients’ data to health professionals at the 
external facility and establish a relationship with them. An alternative approach followed 
by some registrars is to contact their counterparts working at hospitals where care is 
provided. After all the required information is collected and the abstract is considered 
complete, it is saved in the suspense file preparation for submission. The suspense file 
acts as a local temporary database, where completed abstracts are saved before sending 
them to the central registry.  
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 Submission 
 
Completed abstracts are sent to the state registry at fixed intervals. Facilities with 
a higher number of cases are required to report to the state registry at a higher frequency. 
For example, facilities with an annual caseload of 300 or more are required to report 
monthly, while facilities with an annual caseload of 150-299 are required to report every 
other month.  
 
4.3.2 Time per Task 
 
When examining the process cycle time, we see that it contains both activity and 
waiting times. Activity time includes the time registrars spend accessing and retrieving 
data, reviewing the records, and entering information into the system. Meanwhile, 
waiting time refers to the time cases or records reside in the system while no activity is 
being performed. This includes the time cases reside in the suspense file before 
abstracting and the time completed reports reside in the local system before being sent to 
the state registry. A list of the estimated time spent at each phase is available in Table 4-
3.  
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Activity Time Non-Activity Time 
Task Time Phase Time 
    
Case finding from 
pathology reports. 
Daily: 1 hour Suspense file. 3–6 months. 
Varies among 
hospitals. 
Case finding from 
the ICD-9 list. 
Monthly: 1 day Completed cases 
reside at the local 
registry before 
submission. 
An average of 15 
days for hospitals 
with higher 
caseloads.*  
Abstracting Daily: 45 minutes 
to 1½ hours per 
case. 
  
 *Hospitals are considered high load if they have 300 or more reportable cases a year.  
Table 4-3: Estimated time for each reporting phase. 
 
4.3.3 Barriers 
 
Identified barriers were categorized into 6 themes. The most critical and common 
themes identified were access to data at other facilities and case findings from index 
codes. Details of identified barriers are discussed in the following paragraphs.  
 
 Access to Information-Related Barriers 
 
In this context, access to medical records can result from a technical inhibitor or a 
non-technical inhibitor. The technical inhibitor can be seen as the inability to exchange 
data between systems as a result of using legacy systems, a paper system, or data 
interoperability, among others.  
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However, non-technical barriers are often the result of the hospital network effect. 
The network effect can be seen when facilities are parts of different hospitals that do not 
exchange data. Exchanging patients’ records in such cases often requires additional steps 
and additional paperwork to ensure security and confidentiality of the data. Generally, 
cancer registrars work as hospital employees and have access provided by the recruiting 
hospital. Registrars are often able to access data available within the hospital they work 
for, but when patients receive care in a facility outside the hospital network, access 
becomes more challenging. The following section will discuss access-related barriers in 
more details. 
 
 Access to External Records 
 
During abstracting, registrars are required to complete a predefined data file. 
Once the case is identified as reportable at the case-finding stage, registrars will search 
for the required data fields in hospital medical records. In some cases, data is not 
available in local medical records, which occurs when patients receive care at an external 
facility. This is common when dealing with treatment data, as many of the facilities 
providing oncology treatment are external or independent.  
 
Interviews show that registrars were applying different methods to access records 
at external facilities. In some cases, registrars can have electronic access to medical 
records at external facilities or know staff who can provide them with the needed 
information. Examples of electronic access include remote desktop connection, virtual 
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private network (VPN), and Health Information Exchanges (HIE), such as Indiana 
Network for Patient Care (INPC). Remote desktop connections and VPNs are employed 
when many patients visit some specific outside facility so that registrars can ask for 
access or establish a relationship with the external facility.  
 
When registrars depend on staff at the external facility to request information 
(such as nurses or physicians), often they are constrained by staff time and availability. 
Since searching for and sending information to registrars is not part of their core job 
requirement or is a direct patient service, this is done on a voluntary basis.  
 
Interviews show that the percentage of cases that require contacting external 
facilities varies widely, from 10% to 40%. One registrar stated that it can be difficult and 
time-consuming to find out what physicians are doing in their offices; for example, a 
physician might be contacted to find out if the patient received chemotherapy, hormone 
therapy, or refused treatment. While describing the barriers encountered, one interviewee 
stated: 
 
“Getting the information from them ‘physicians and nurses’ and letting 
them know they are not breaking HIPAA if they give us this information. 
Telling them even if we are not face-to-face with the patients, we are still 
doing patients’ care.” 
 
The interviewee also stated that physicians who are active on cancer boards are 
more likely to help, because they understand both the process and the needs of cancer 
registries.  
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Staff at external facilities are contacted through phone calls, mail, or faxes. The 
method of contact and the access granted varies based on each registrar’s ability to 
establish a relation with the external facility. An interviewee stated that, being a non-
contracted registrar makes it more difficult to collect information from external facilities. 
The interviewee stated:  
 
“Because I am not a contracted employee, I tend to go onsite and meet 
people. I don’t call a lot, because some places are not happy giving that 
information. They want to know who I am and where I am from, so the 
contact I do have, I build a rapport with and I get the information from 
them.” 
 
Since the majority of interviewees experienced some level of barrier to access, the 
extent of the issue varies between registrars. Registrars who experienced fewer obstacles 
with data access also stressed the need to build a rapport and know staff at other 
departments and nearby facilities.  
 
When patients receive treatment at an external facility, the abstracting registrar 
sometimes contacts the registrar working for that facility, instead of contacting the 
physician or nurses. This is often expressed as a preferable alternative, because they are 
familiar with the reporting process and requirements. The state registrars’ association 
provides the registrars’ directory, but our results show that few registrars have used it or 
mention it during the interview.  
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Another barrier is knowing where the patient has been transferred to. One 
interviewee stated that the real obstacle comes with finding out where patients receive 
treatment, as this is not always indicated in their medical records. When this is the case, 
registrars need to guess, using the patient’s address and nearby facilities.  
  
 Technical Barriers 
 
Access barriers related to technical issues were less common. In this context, 
system compatibility was indicated as being an issue. Although it did not prevent 
registrars from accessing the needed information, it prevented them from using the 
oncology management system to its fullest potential.  
 
One registrar stated that the hospital system doesn’t support some of the 
technology they wish to use. Because the hospital system is not compatible with the 
oncology management reporting system, registrars were not able to use all of the features 
that require data sharing.  
 
 System Integration and Electronic Data Exchange 
 
System integration can support the case-finding process. In most cases, data 
needed for case finding is retrieved electronically from case-finding sources, such as 
pathology reports and disease indices. Disease indices, for example, are retrieved 
electronically by health information management departments. Screenings for disease 
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codes function as a wide net that form an inclusive search that screens for cancer-related 
codes. However, this itself is not enough for case ascertainment. Once the case is 
identified as potentially reportable, registrars will search other data sources, such as 
pathology reports, surgery reports, and physicians’ notes, in order to confirm case 
repeatability. 
 
This process can be time-consuming, because registrars have to search and review 
several data sources before they can decide whether or not the case is eligible for 
reporting. The list of International Classification of Diseases (ICD) codes used for 
screening is inclusive, which often results in a large number of non-reportable cases. In 
many cases, patients with a history of cancer are flagged in the system and added to the 
disease indices list. To distinguish the history of cancer from newly diagnosed cases, 
registrars will need to check the local registry to figure out if the case has been previously 
reported. 
 
With large numbers of cases, relying on human skills to distinguish the new from 
previously reported cases can be difficult and time-consuming. Some oncology 
management systems provide tools to help with records matching. Using such tools often 
requires system integration and data sharing. Currently, EMR screening is performed by 
the health information department on a weekly or monthly basis, and the list is then sent 
to the registrars in Excel format. Using a hospital EMR and oncology management 
system that is not comparable will prevent data sharing and thus prevent using some of 
the oncology management system tools that require data sharing. This also happens when 
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the hospital system relies on a paper format for data sharing. Interviews show that 
departments that use a paper-based system will send their records in paper format; 
whereas, others sometimes fax to share their data. 
 
 System Login and Session Timeout 
 
Abstracting requires the collection of a significant amount of data from different 
sources using different systems. Due to HIPAA regulations, access to medical records is 
protected in a variety of ways. One measure is the automatic logging-out of users who are 
inactive for a set period of time. Due to the large number of data needed from diverse 
sources, registrars sometimes need to go back and forth between these data sources, 
which include accessing different systems, paper records, or phone calls. However, being 
busy with one source will result in inactivity in the previous one, and, in turn, the system 
will log the user out automatically. One registrar commented: 
 
“My most time consuming thing for me lately is getting the medical 
records to work, logging in to the system, staying logged in, and dealing 
with connection.” 
 
This is more problematic when hospitals use segregated systems. For example, 
when patients are diagnosed in a hospital that refers patients to the Radiology Department 
that uses a different system, registrars will need a different system in order to access the 
radiology records. In some cases, where registrars are working remotely or from home, 
they will often require a VPN in addition to their login credentials.  
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 Cognitive Load 
 
One commonly time-consuming part of abstracting is the mental load. A mental 
load can arise when registrars are trying to predict the sequence of events that patients 
went through and when registrars are trying to interpret information provided in the 
physician’s notes.  
 
During case abstracting, registrars search for the diagnosis, procedures, and 
treatments the patients received. They collect information from multiple sources and 
arrange it in chronological order, thereby, building a series of events. Building this series 
of events often requires vast knowledge and experience in cancer. Moreover, it requires a 
familiarity with the protocols of the facility, as well as the resources available. One 
interviewee described the process as putting pieces of a puzzle together, where they try to 
find the answer to what they are looking into. One registrar commented: 
 
“When you do that abstracting for patients, you are writing their story, you 
are the author. You want to make sure you have all the facts, the dates, the 
treatment collection, date of birth, name, so when you write, your 
comments, you have to be clear as to what happened to that patient.” 
 
The sequence of events has to follow a logical treatment path using the available 
data. This process can become complicated when some of the expected events (such as 
treatment or procedures) are missing. Registrars will then try to find out which data is 
missing or which procedures were not performed.  
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The second factor that contributes to mental load is interpretation of the 
physician’s notes. Some of the information that needs to be reported is usually found in 
the physician’s notes. Although physicians’ notes can have a lot of the information that 
registrars need, they are not designed for that purpose, but rather they are unstructured 
and written as text. Moreover, the terminology used may differ from what is required by 
central registries. After finding the required information, registrars will have to interpret 
the notes and make sure they answered the questions posed by the central registry. 
Interpreting this information requires not only a solid understanding of the domain, but 
also an understanding of the patient’s individual situation and contexts.  
 
 Many False Positive Cases Identified from ICD-9 Codes 
 
As described previously, case finding is the process of identifying newly 
diagnosed cases that need to be reported. The second commonly used source for case 
findings after pathology reports is the ICD-9 list. During the case finding, registrars 
search for codes relevant to cancer. Searching a hospital’s database for a predetermined 
set of codes may have the added advantage of leveraging technology for fast retrieval. 
However, this may result in many non-reportable cases also being retrieved by the 
system. The range of the estimated cases identified through ICD-9 lists reported by 
interviewees was only 2.5% to 11%. To filter them, registrars manually review the results 
and verify their eligibility for reporting.  
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One reason that a retrieved result may not be reportable is that a patient has a 
history of cancer. During the manual review, registrars will need to determine whether it 
is a new case that needs to be reported, there is a history of cancer, or this is a second 
primary or recurrent incident of cancer. For instance, in the pathology reports in which 
90% to 95% of case findings are identified, classification can be determined by reading 
the report. However, with the disease indices, classification will be much harder to 
determine, because registrars receive a list of codes, often in ICD-O, with insufficient 
details to classify.  
 
When the case is identified through the indices code and there is no pathology 
report available, the physician’s notes might be used. However, registrars have reported 
some issues associated with physicians’ notes, such as lack of information and 
ambiguous terminology. When this occurs, registrars will search additional sources to 
determine case repeatability. Such a review process can be difficult and time-consuming, 
especially because a large number of cases are often found to be non-reportable. 
 
 Case Related Barriers 
 
Registrars seem to agree that abstraction time can vary widely among cases. That 
variation was not only found among cancer types, but also among different cases within 
the same cancer type. The results show that some cancer types are known to be more 
time-consuming than others. Most interviewees have indicated that head and neck cancer 
is often harder and requires more time to abstract. Registrars have often indicated that 
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cases referred to as complicated, such as head and neck, generally take longer to abstract 
than simpler cases, such as breast or lung. With head and neck cancer, patients could 
receive multiple treatments and procedures, where the treatment path can be more 
complicated than other cancer types. Moreover, due to the nature of the close overlapping 
anatomy in the head and neck, it may take longer to determine the amount of tissue 
involved and the extent of tumor spread. Unlike head and neck cancer, kidney cancer is 
known for requiring less treatment and is often easier and faster to abstract. The results 
also show that even within the same cancer type, some cases may take longer than others. 
 
 Additional Activities 
 
Some registrars have indicated that administrative tasks, such as reviewing 
compliancy and serving on a tumor board or cancer committees, could be time-
consuming. For instance, the frequency of committee board meetings can range from 1-
to-6 per month, depending on hospital size and activities. Meetings require preparation of 
reports, and PowerPoint presentations, among other documents. Additionally, cancer 
committees can be conducted 4 times a year, at which times registrars have to review all 
standards (around 25), make goals, and vote. It is important to note that our interviews 
were focused on the time needed to report to the state registry, whereas most hospitals are 
also required to report to the Commission on Cancer (CoC) and the state registry. One 
registrar commented: “If I just abstract for the state, I would be part-time.” 
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In addition to reporting, the CoC requires participating hospitals to perform 
continuous follow-ups, which involve updating patient status, cancer status, any 
recurrence, new cancer, or new treatments. To perform follow-ups, registrars continue 
searching and updating patient information for life.  
 
Other barriers were software-related. Some registrars indicated that open-source 
software, like Rocky Mountain, only provides basic features and does not provide any of 
the additional functionalities that can promote an efficient workflow, especially for 
matching cases and case follow-up. 
 
Although registrars were using different systems, most of them tend to agree that 
abstracting time ranges from 45 minutes to 1.5 hours. Variation in the usage of oncology 
management systems seems to have been more significant at the case-finding and follow-
up stages, with activities such as matching records and importing data, than it did at the 
abstracting phase. Only one registrar reported dissatisfaction with the Rocky Mountain 
system at the abstracting stage, and that dissatisfaction was related to checking for errors 
after report completion.  
 
 Physician’s Notes and Information Contradiction 
 
A less common barrier identified during abstracting is contradiction in 
information found in the records. As described previously, registrars collect information 
from various sources to describe patients’ cases and the treatment path that was followed. 
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In some rare cases, registrars find contradictions between these sources, such as 
physicians’ notes and pathology reports, or even within physicians’ notes. Contradictory 
information is not common, but it can be found more often when multiple physicians 
treat the same patient. The results also indicated that, when this happens, it is often a 
complicated case.  
 
Another barrier is cancer confirmation. Most cancer diagnoses are confirmed 
through biopsy, but when pathology reports are not available, other information sources, 
such as physicians’ notes or diagnostic imaging reports, are used. The difficulty arises 
when uncertain language is used. Terms like “probable, suspected, likely, questionable, 
or possible” will lead registrars to seek more data sources for diagnosis confirmation.  
 
4.3.4 Redesigned Workflow  
 
The redesigned workflow focused on minimizing the time cases reside in the 
suspense file, as well as facilitating communication between registrars and their access to 
information. To achieve this, we proposed the following: 
• An electronic pathology (E-path) reporting system 
• A notification system for treatments 
• A secure messaging system  
• Access to HIEs, such as INPC 
Incorporation of the above elements into the workflow process is illustrated in Figure 4-
11. 
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Figure 4-11: Cancer reporting flow chart (systems added in the redesigned workflow). 
 
 Workflow Steps 
 
Figure 4-12 shows the flowchart for the proposed workflow. The steps for the proposed 
workflow will be as follows: 
 
1. Cancer cases are identified through pathology reports using an automated tool (E-
path).  
2. Registrars visually check cases identified by E-path for reporting eligibility. 
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3. Case findings from other sources are done manually by registrars and matched 
with pathology reports (if available). 
4. Cases identified as reportable are saved into the suspense file for abstracting. A 
copy of the identified cases is sent to the state registry and marked as incomplete.  
5. EHR sends a notification to the oncology management system of any new cancer-
related treatment. If the notification matches any of the cases in the suspense file, 
then the case will be flagged. 
6. The registrar will check flagged cases and start abstracting. If no new treatment is 
received within 6 months of the case finding date, then the registrar will start 
abstracting and check the physician’s notes and discharge notes regarding whether 
treatment was provided elsewhere. 
7. If an abstract is completed, then it is reported to the central registry. If treatment is 
received at an external facility, then the registrar will search the HIE—INPC in 
this case—for additional data and use the secure messaging system to contact 
registrars at the external facility. 
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Figure 4-12: Cancer reporting flow chart (redesigned workflow). 
 
4.4 Phase 4:Simulation  
 
4.4.1 Current Process Simulation 
 
The simulation was constructed using Anylogic software version 7.1. The current 
workflow was simulated using Discreet Event Simulation (DES). The flow of data and 
reporting steps were analyzed and the time spent was measured. The simulation model 
was then validated to reflect the actual processing time. Details of the validation process 
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are described in the methods section. The simulation diagram elements and model are 
described below (Table 4-4, Figure 4-13). 
 
Entity Location Service Action 
Tumor case Case finding 
(pathology and 
indices codes) 
Add the new incoming pathology 
reports and indices codes. 
Source 
Tumor case Case finding 
(pathology and 
indices codes) 
Stack incoming pathology reports 
to be reviewed. 
Queuing 
Tumor case Case finding 
(pathology and 
indices codes) 
Review pathology reports by 
registrars. 
Services 
Tumor case Case finding Supply registrars to perform the 
case finding. 
Resource pool 
Tumor case Filtering Filter non-reportable cases. Select output 
Tumor case Case finding Remove non-reportable cases. Sink 
Tumor case Suspense file Store cases while waiting for 
treatment and other procedures to 
be performed. 
Delay 
Tumor case Abstracting Split cases requiring data retrieval 
from external sources from those 
available in local records. 
Select output 
Tumor case Abstracting Abstract patients’ information. Delay 
Tumor case Save completed 
reports 
Stack cases before reporting to 
the central registry. 
Delay 
Tumor case Reporting Report to the central registry. Sink 
Table 4-4: Description of simulation model parameters. 
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Figure 4-13: Cancer reporting (current status) discrete events model. 
 
The simulation shows the lower, average, and upper times needed for reporting. Running 
the simulation for the existing workflow resulted in the following: 
  
Running Time Reporting Time (min, avg., max) 
Business Days Calendar Days Business Days Calendar Days 
260  One year  (73, 99, 127) (102.2, 138.6, 
177.8) 
520  Two years (73, 99,129) (102.2, 138.6, 
180.6) 
Table 4-5: Simulation output (current status).  
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4.4.2 Proposed Workflow Simulation 
 
This section describes simulation of the proposed workflow. For the proposed 
process, the time that cases should reside in the suspense file could not be estimated by 
the registrars who were interviewed. However, the registrars seemed to agree that this 
time can vary, largely based on factors like cancer site, stage, and hospital resources. To 
estimate this time, we used previous studies that calculated the time between diagnosis 
and treatment (Bilimoria et al., 2011). The study analyzed 1,228,071 patient records from 
1995 to 2005. Data retrieved from the National Cancer Database represented around 
1,443 hospitals in the U.S. The results included the median days and interquartile range 
waiting times for breast, colon, esophageal, gastric, liver, lung, pancreatic, and rectal 
cancers. Our study focused on breast, lung, and colorectal cancer. The waiting time for 
breast, lung, and colorectal cancer was (14; 24–40), (20; 37–63), and (13; 26–46), 
respectively.  
 
The proposed notification system was simulated for the 3 cancer types studied 
(breast, colorectal, and lung). Based on the Indiana “Cancer Facts and Figures 2012” 
report, the distribution among these 3 cancer types was as follows: 33% breast, 26% 
colorectal, and 41% lung (ISDH, 2012). This distribution was used to simulate the 
probability of cases added to the suspense file.  
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The simulation for the proposed model can be seen in Figure 4-14. The results of 
the proposed model simulation can be seen in Table 4-6. The redesigned process 
simulation shows an average reporting time of 51 days, compared to 138 days with the 
current process simulation (Table 4-7).  
 
Running Time Reporting Time (min, avg., max) 
Business Days Calendar Days Business Days Calendar Days 
260 One year (14, 37, 68) (19.6, 51.8, 95.2) 
520 Two years (14, 37, 72) (19.6, 51.8,100.8) 
Table 4-6: Simulation output (redesigned status).  
 
Simulation Time Existing Reporting Time 
(min, avg., max) 
Redesigned Reporting Time 
(min, avg., max) 
One year (102.2, 138.6, 177.8) (19.6, 51.8, 95.2) 
Two years (102.2, 138.6, 180.6) (19.6, 51.8,100.8) 
Table 4-7: Comparing simulation output (current and redesigned status). 
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Figure 4-14: Cancer reporting (redesigned workflow) discrete events model.  
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 DISCUSSION  CHAPTER 5:
 
5.1 Introduction 
 
The goal of this study was to evaluate the timeliness of cancer registry reporting 
while exploring ways that the reporting process might be improved. This study was 
motivated by the increasing demand for timely cancer data to support research, quality 
care, and public health surveillance. Phases 1 and 2 of the results evaluate timeliness of 
data reported to the state registry and steps within cancer reporting processes, 
respectively. Phase 3 explores the barriers encountered during reporting and offers a 
redesigned workflow for timelier, more efficient reporting.  
 
As described in previous sections, cancer reporting involves a series of steps that 
include case finding, abstracting, and submission, all of which are fundamental to the 
reporting process. Reporting steps involve the information search, retrieval, and 
comprehension, in addition to data entry. To situate the evaluation, it is necessary to 
understand the steps involved, the time needed, and the challenges experienced during 
each stage. 
 
Previous studies have evaluated timeliness in cancer reporting by measuring 
reporting time as a single process from start to finish. Although this provides a clear 
indication of the overall reporting time, the exact duration of each stage within the 
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process remains unknown. By separating this process into multiple steps, we gain more 
detailed information about reporting efficiency at both the organizational and state level.  
 
In a review by Jajosky and Groseclose (2004), the authors concluded that 
surveillance and timeliness studies in public health lack detailed descriptions of reporting 
stages, such as processing and analyzing. Their review also emphasized that both 
collection and assessment of time interval dates are an important part of any surveillance 
system or timeliness assessment (Jajosky & Groseclose, 2004).  
 
The novelty of our study involves leveraging the time interval dates to analyze the 
reporting process historically and at the state level. Doing so enables us to calculate the 
time each step took within the reporting process, as well as examine changes in 
timeliness for each step over the years.  
 
Examples of the knowledge acquired using this approach include: the time taken 
by the reporting facility to abstract the case report and send it to the registry, the time 
taken by the facility to complete the abstracts, the amount of time completed reports 
remain at the facility database before being sent to the state registry, and the time taken 
by the cancer registry to process the report and upload it to their database. 
 
Longitudinal data (over the course of 9 years) enabled us to assess changes in reporting 
timeliness for each step. As seen in Figure 4-4, the time taken by the state registry, for 
instance, was reduced significantly by 2004.  
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A key benefit of the applied method is the granularity of results, because the 
outcomes were stratified by different facilities. The stratification allowed us to determine 
whether observed timeliness for a given step is universal or unique to a particular facility 
or step. One example is the variation among facilities in the time taken to send completed 
reports to the state registry.  
 
Time intervals at each step were utilized to identify potential causes for observed 
delays at some facilities, and some facilities were found to keep completed records at the 
local database longer than expected. The interviews offer one possible reason for the 
delay: an uneven flow of patients visiting the facility. Patient flow, in turn, is affected by 
holidays and the rush at the end of the year to meet health insurance deductibles. Using 
time intervals allowed us to check the distribution of cases, the time of diagnosis, the 
time of report completion, and the time of report submission. 
 
Whereas prior studies examined timeliness as part of a data quality evaluation, 
they generally lacked description of the reporting process. While this emphasis is helpful 
with understanding the quality of data, it does not provide sufficient knowledge of the 
efficiency of the process or how the reporting process could be improved. 
 
In this study, we investigated the process of data production by collecting 
objective and subjective data. Objective data was obtained from dates and timestamps to 
evaluate the process at the state level over an extended period of time. Subjective data 
were collected during registrar interviews, and it provided deeper insight into the details 
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of the process. To explore this understudied area, we conducted semi-structured 
interviews to support the grounded-theory approach of deeper understanding and theme 
discovery. During the interviews, registrars were also encouraged to think beyond 
technical limitations through “blue sky” thinking.  
 
5.2 Timeliness Overview 
 
The results showed a sharp increase in reporting time during 2003, which was 
concurrent with changes in the policy and procedure requirements for reporting facilities. 
Starting in 2003, the ISDH Cancer Registry implemented the Facility Oncology Registry 
Data Standards (FORDS) coding standard. FORDS was developed by the Commission on 
Cancer (CoC) and is now required by all CoC-approved cancer programs to define data 
collection and coding requirements. Another 2 major changes occurred in 2004. By the 
beginning of that year, reporting facilities were required to report all benign and 
borderline brain and central nervous system (CNS) tumors. Additionally, the ISDH 
Cancer Registry also required all reporting facilities to start coding using the 
Collaborative Staging System (ISDH, 2004).  
 
Recent studies indicate the importance of the secondary use of data and the role of 
health information systems in supporting this use. Special attention has been given to 
cancer and the importance of data in understanding and improving treatment and care. 
Accessibility of recent data is key for timely intervention and quality improvement 
(Abernethy et al., 2010). Currently, our results show an average timeliness of 323 days, 
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which suggests that data users will have to wait that amount of time after diagnosis 
before they can access this data via the state cancer registry. Our results also show that 
researchers are able to access an average of 17.6% of cases within the first 6 months of 
diagnosis, 68.7% after the first year, and 96.5% after 2 years. The percentage of cases 
available within these time periods improved as of 2009, reaching 37.2%, 82.6%, and 
97.5% for 6 months, 1 year, and 2 years, respectively. Although this seems like a long 
time from a research perspective, it is tacitly accepted by most national registry 
standards. 
 
National cancer registries provide funding to participating hospitals and states to 
collect cancer data. Participation in cancer registry programs requires meeting their 
standard for data quality. The following paragraphs will discuss the timeliness of ISDH 
Cancer Registry data compared to some of the most common cancer registry standards.  
 
The ISDH Cancer Registry was certified gold by NAACCR in 2001, 2002, 2004, 
2006, 2007, 2008, and 2009. Gold certification requires 95% of cases to be reported 
within 23 months from the date of diagnosis. In 2003, 2005, and 2010, the ISDH was 
silver certified, indicating that 90% or more of the cases were reported within 23 months 
(NAACCR, 2015).  
 
Compared to our results, the percentage of cases reported within the first 23 
months was 95% or higher, except in 2004, 2006, and 2008 (Table 5-1). The discrepancy 
between the NAACCR certification level and our results can be found in Table 5-2, but, 
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in general, the difference was less than 1%. Such a small amount illustrates that our data, 
although limited to a subset of cancer types, was representative of all data reported to 
ISDH. Furthermore, it underscores that ISDH is meeting the timeliness requirements for 
NAACCR. However, there is still room for improvement in meeting the timeliness 
standard for SEER, or for enhancing efficiency of the process. 
 
 Months 
(N) 
2001 2002 2003 2004 2005 2006 2007 2008 2009 
12 
 
71.4% 82.1% 34.4% 59.2% 68.8% 76.6% 74.7% 70.6% 82.6% 
22 
 
97.1% 98.3% 93.7% 93.3% 94.3% 94.2% 95.3% 92.9% 97.5% 
23  
 
97.6% 98.5% 95.0% 94.1% 95.3% 94.7% 96.0% 94.5% 97.8% 
24  
 
98.1% 98.8% 95.8% 94.8% 95.7% 95.3% 96.6% 95.9% 98.2% 
Table 5-1: Comparing national registry timeliness standards to our results. 
 SEER 98% within 22 months. 
 NACCAR: Golden 95% within 23 months. 
 NACCAR: Silver 90% within 23 months. 
 CDC/NPCR 12 months for reporting 90% of cases after the date of diagnosis or 
24 months for 95%.  
 
Year Certification level Target Our results Discrepancy % 
2001 Gold 95% 97.6% 0 
2002 Gold 95% 98.5% 0 
2003 Silver 90% 95.0% 0 
2004 Gold 95% 94.1% 0.9% 
2005 Silver 90% 95.3% 0 
2006 Gold 95% 94.7% 0.3% 
2007 Gold 95% 96.0% 0 
2008 Gold 95% 94.5% 0.5% 
2009 Gold 95% 97.8% 0 
Table 5-2: Comparing NAACCR certification level to our results. 
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Another known cancer registry standard is SEER. Currently, the ISDH registry is 
not part of SEER. To meet the timeliness standard for SEER, state registries are required 
to report at least 98% of their cases within 22 months from the date of diagnosis (Table 5-
1) (NCI, 2014). Our results show that SEER standards were only satisfied in 2002, with 
98.3% of the cases reported within 22 months. For the remaining 9 years, the highest 
percentage of cases reported within 22 months was 97.1% in 2001 and 97.5% in 2009, 
respectively.  
 
The third cancer registry standard is CDC/NPCR. The ISDH is currently 
participating in CDC/NPCR, which allows 12 months for reporting 90% of cases after the 
date of diagnosis and 24 months for 95% of cases (CDC, 2013). Our results show that the 
percentage of cases reported within 12 months was less than 90% for the entire 9 years. 
However, the percentage was higher than 95% within 24 months for all 9 years except in 
2004, when it was 94.8% with a 0.02% difference (Table 5-1).  
 
Our study only included 3 of the most common types of cancer, while national 
registries consider all cancer types. The low variation in reporting timeliness among the 
different cancer types may have led to a more accurate estimation. Moreover, registry 
standards take several DQ measures into account, including measures like the missing 
data rate and the overall data validity. The NAACCR gold certification, for instance, 
requires the following:  
• less than 3% of cases use a death certificate for identification,  
 98 
• less than 1% are duplicate files,  
• 100% error-free for some variables,  
• less than a 2% missing rate on age, sex, and county, and less than a 3% missing 
rate on race (NAACCR, 2015). 
 
The calculation method used to arrive at these results should also be considered. 
Where some studies use a date stamp to calculate the difference between the start and end 
date, others use the observed and expected number of cases. In this study, we calculated 
the difference between the date of diagnosis and the date when the data was made 
available on the state registry by using data items that conform to NAACCR standards. 
However, the CDC/NPCR uses the observed-to-expected ratio to determine the rate of 
completeness within a specified period (CDC, 2013). This method uses the registry’s 
previous reporting experience to determine an expected number of cases. Because this 
method may have the advantage of estimating rates of completeness for recent years, 
historical data can leverage the date stamp for a more accurate measurement. This is an 
especially important factor if the number of annual incidents is inconsistent. The annual 
number of cases included in this study range from 6,693 to 7,726, with the lowest being 
6,693 observed in 2009. Due to the lengthy process of cancer reporting, cases diagnosed 
within recent years often take more time to be reflected. 
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Prior work reported that timeliness varied by cancer types and the variation was 
explained by the fact that different types of cancer are often diagnosed and reported by 
different sources, such as hospitals, laboratories, or physicians’ clinics (Smith-Gagen et 
al., 2005). Gagen et al. (2005), for example, reported that breast and colorectal cancer are 
often diagnosed and reported by hospitals and, therefore, tend to be reported quicker than 
melanoma or prostate cancers, which are often diagnosed and reported by non-hospitals 
(Smith-Gagen et al., 2005). In our study, the 3 cancer types examined showed similar 
reporting times. The impact of the reporting source on timeliness could not be examined 
in our study, because around 98% of the cases used were reported by a hospital. A 
recommendation for future studies is to examine the variation in timeliness by reporting 
source.  
 
Our study shows similar reporting times for the 3 cancer types. The difference in 
average reporting time was insignificant, with a high of around 35 days during 2008. The 
similarity in reporting times among the different cancer types could be explained by 
understanding the reporting workflow. As seen in Part 3 of the results, different cancer 
types are grouped together and processed similarly (more details in Phase 3 of the 
results).  
 
5.3 Reporting Stages Timeliness 
 
A key step for process improvement is identifying the steps that consume most of 
the reporting time. Reporting time can be affected by many factors, including caseload, 
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access to information, disease type, and staffing. Such factors are often assessed through 
subjective tools, including surveys and interviews.  
 
To enhance our understanding of the impact of these factors and to understand the 
extent to which each affects timeliness, we also used objective data. Each factor can 
affect different stages of the reporting process, and in Phase 2, we examined the time 
taken at each stage. The main stages examined were registry processing time, report 
submission time, and report completion times. 
 
Phase 2 also examined the variation in timeliness among reporting facilities. Phase 1 
shows that the overall timeliness of cancer report submissions to the State’s Department 
of Health did not differ based on the type of cancer. However, vast differences in 
reporting time between cases was demonstrated by the widely distributed box plots. In 
this section, we examine the differences in reporting time among facilities. 
 
5.3.1  Registry Processing Time 
 
By separating the time taken for case finding, abstracting, and report submission 
at each facility from receipt of the reports, we found that the registry requires a very short 
amount of time for processing. A remarkable reduction in registry processing time was 
found after 2004. By 2004, the time taken by the registry to process and edit the cases 
received started to decrease from 20 to 30 days to only a few days (less than 10 days). 
Additionally, the variation in processing time among cases substantially decreased after 
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2004; whereas in 2002 and 2003, processing time could extend up to 75 days, and in most 
of the remaining years from 2005 afterward, all cases were processed in less than 10 
days. The change in processing time was concurrent with implementation of a registry 
system using the File Transfer Protocol (FTP) (ISDH, 2004). FTP is an Internet protocol 
standard for exchanging files online. It was implemented to substitute the traditional 
means of physically sending discs. Submitting reports online can enable the real time 
transfer of data compared to post mail. 
 
5.3.2  Report Completion Time 
 
To further examine timeliness at the level of reporting facilities, we separated the 
time taken to complete the reports from the time taken for submission. The results show 
clear variability in reporting speed among facilities. Whereas most facilities took 175–
200 days to abstract and complete reports, some took almost 300 days. Many factors, 
such as staff numbers, hospital recourses, or registrars’ access to medical records, could 
have influenced variability in report completion time. 
 
Abstracting cancer reports is a labor-intensive and time-consuming process. 
Cancer registrars are required to go through long training sessions and pass certification 
requirements. Registrars need to meet demand, and shortages of qualified registrars 
appears to be common. In 2004, Tangka and Subramanian et al. conducted an economic 
evaluation study on the 4 central registries in operation. The study collected information 
with the aim of quantifying the cost effectiveness of registry operations. The study 
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reported that staffing shortages were the most frequently cited problem. Staffing 
shortages were reported by more than 50% of the registries and over 70% of the reporting 
facilities (ACS; Tangka, Subramanian, Beebe, Trebino, & Michaud, 2010). 
 
The number of registrars needed often depends on the facility’s caseload. Though 
the number of diagnosed cases was nearly equally distributed across different quarters in 
the same year, the annual caseload at the same facility was inconsistent across years. This 
means that patients come to facilities at a constant rate within the same year, but the 
number of patients coming from one year to the next can change significantly. In facility 
1 (Appendix 6-2), for instance, the number of reportable cases for the 3 cancer types 
diagnosed in 2007 was around 300, and it nearly doubled in the subsequent 2 years, 
reaching around 600 cases in 2009. Similarly, with facility 6 (Appendix 6-2), the number 
of reportable cases diagnosed during 2005 was less than 100 cases, but this number 
increased to nearly 175 cases in 2008. To enable facilities to complete reports at the same 
speed, they need to maintain a consistent registrar-to-caseload ratio. Having a highly 
inconsistent number of cases diagnosed each year creates staffing challenges. 
 
Hospital structures and registrars’ access to medical records also can affect report 
completion times. Hospitals with segregated systems require more time and effort to 
collect the information needed to complete the reports. The use of segregated systems can 
be attributed to technical or organizational reasons. One technical reason involves having 
a paper-based or legacy system that is hard to access. However, organizational reasons 
can include having outside facilities that are not part of the same hospital network. If 
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patients are diagnosed in an office, for example, and receive treatment or procedures at an 
independent facility with a separate medical records system operated by another 
organization, registrars will have difficulty accessing these patient records. Such a 
situation can prolong the time taken to complete the report, and it is more common when 
patients tend to receive care at multiple locations. 
 
5.3.3  Report Submission Time 
 
Similar to reporting completion times, variations among facilities reporting 
submission times was examined by calculating the average submission time for facilities 
with higher caseloads. Both report completion time and report submission time showed 
variability among facilities; however, a much higher variability was found in report 
submission times. In this context, submission time refers to the time between report 
completion and receipt of the report at the state registry. 
 
In this study, 22 out of 49 unique facility IDs were classified as higher-load 
facilities. These 22 facilities accounted for 90.5% of the total number of cases, leaving 
only 9.5% for the remaining 27 facilities. By examining report submission times at the 22 
facilities, we identified 7 facilities that took significantly longer than others (at least twice 
as long). Although a longer submission time was found only in 7 of the 22 higher-load 
sources, those 7 accounted for around 28.4% of the total number of reported cases. Such 
a high percentage can heavily affect registry standards. With most cancer registry 
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standards, the completion rate is weighted heavily. The SEER standard, for instance, 
requires 98% of the cases to be reported within 22 months of the date of diagnosis. 
 
Nowadays, transferring reports from facilities to state registries is mostly handled 
electronically. Unlike case finding and abstracting, submitting reports is easier and less 
time consuming. One way to speed up the reporting process is to encourage facilities to 
submit completed reports more often. Submitting reports more promptly can potentially 
improve overall registry performance, especially if facilities with longer submission 
times are targeted. The observed difference in how quickly reports are submitted among 
facilities could also indicate a variation in their reporting practice. This highlights the 
need for examining variations in reporting practices among facilities. 
 
5.3.4  Reporting Frequency 
 
Submission time was further examined by calculating the frequency of reporting. 
In this step, we focused on facilities with longer submission times. Those reporting 
facilities classified as high-caseload facilities in this part of the analysis were expected to 
report their cases every 90 days or less. The results show that the distribution of cases 
submitted every quarter differed from facility to facility. In some years, facility 6 and 20, 
for instance, submitted all their annual cases in one quarter. 
 
We examined the frequency of reporting in previous steps to decide whether the 
frequency of irregular reporting originated during the submission time or was inherited 
 105 
from prior steps. The results also show that both the rate of cases diagnosed and the rate 
of reports completed within a given year were relatively equally distributed most of the 
time. This suggests that the irregular reporting frequency observed during the report 
submission phase occurred at this step and was not inherited from previous steps. It also 
suggests that barriers to regular reporting are unlikely to be encountered during the 
diagnosis or report completion phases. 
 
One of the barriers observed during the diagnosis phase was the irregular flow of 
patients in a given year, which means that patients visited the facility and were diagnosed 
more during certain seasons. At the report completion phase, the frequency of irregular 
reporting can occur when more registrars (e.g., part-time or contract employees) work 
during particular quarters. Another potential cause for irregular reporting involves having 
more patients receiving treatment, tests, or procedures that are needed to complete the 
report during certain quarters. 
 
5.4 Barriers to Timely Reporting 
 
The identified barriers encountered during the reporting process were categorized 
into 6 themes. The most critical and common themes were access to data at other 
facilities and case finding using index codes. The table below lists the identified themes 
in their order of importance.  
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Identified Themes Key Barriers Identified 
1) Access to information-
related barriers. 
• Difficulty accessing information within facilities 
that are outside the hospital network. 
• Data exchange between electronic systems. 
• System session timeout. 
2) Many false-positive 
cases identified from the 
ICD-9 codes. 
• A large number of non-reportable cases that are 
flagged for review.  
• ICD-9 codes are not sufficient for confirming the 
repeatability of flagged cases.  
• Some systems do not have the ability to 
distinguish previously reported cases from new 
cases. 
3) Cognitive load-related 
barriers. 
• Combining different events into a single coherent 
abstract.  
• Interpreting some of the information in the 
medical records and translating it to fit registry 
requirements.  
4) Case-related barriers. • Cases with overlapping anatomy. 
• Complicated cases with many procedures.  
5) Additional activities 
required. 
• Administrative tasks, such as reviewing 
compliance, as well as serving on the tumor board 
and cancer committees. 
• Reporting for other institutions, such as the CoC, 
with different requirements. 
6) Physicians’ notes and 
information. 
• Different treating physicians sometimes report 
contradictory information.  
• Text reports using uncertain language, such as 
“probable,” “suspected,” “likely,” “questionable,” 
and “possible.” 
Table 5-3: Summary of barriers to timely reporting.  
 
During the interview, registrars were encouraged to describe optimal cancer 
reporting mechanisms through “blue sky” thinking. By asking them to describe optimal 
status, the responses often focused on eliminating the barriers they encountered. For most 
registrars, optimal status was associated with better access to information or easier case 
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findings. Access to information was expressed as more access to medical records or 
envisioning a central database for all information.  
 
However, easier case finding was often associated with system integration and the 
ability of a system to exchange information. Registrars wanted system integration to 
enable record matching during the case-finding process. As described above, matching 
potentially reportable cases with previously reported ones can help registrars identify 
duplicates and focus on the new cases. This function is available in some commercial 
oncology management systems, but it requires a level of compatibility between the EHR 
and oncology management system used.  
 
Only 3 registrars associated optimal status with automating the reporting process. 
One registrar referred to E-path as a successful example of automation in cancer 
reporting.  
 
5.5 Workflow Recommendations 
 
The Results Chapter presented several barriers to timely reporting. Many of the 
identified barriers can potentially be minimized by redesigning the workflow at the 
hospital level. Another alternative approach is to leverage the HIE for centralized 
workflow. In this section, we will discuss 2 approaches to redesigning reporting 
workflow: hospital-based and national-based (centralized) workflow. 
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5.5.1  Hospital Based Workflow 
 
The Results section described a recommended workflow at the hospital level. To 
assist registrars with case finding from pathology reports, we recommend using the E-
Path system. The redesigned workflow that we also recommend minimizes the time cases 
reside in the suspense file by using a notification system for treatment. Finally, we 
recommend utilizing HIE and the secure messaging system during the casefinding and 
abstracting phases.  
 
 Electronic Pathology Reporting System (E-path) 
 
As indicated previously, 90–95% of cases identified at the casefinding stage are 
identified through pathology reports, followed by the ICD-9 list and others (Appendix 6-
3). The number of cases that need to be reviewed during casefinding can be reduced 
using the E-path system. E-path utilizes a text mining to automate the identification and 
coding of pathology reports. Using E-path for casefinding has been shown to improve 
reporting timeliness and increase reporting efficiency (Dale, Golabek, & Chong, 2002). 
Many states adopted E-path in their workflow to save registrars time and reduce 
casefinding times. Some of the challenges include the cost associated with the software 
implementation and infrastructure needed to send HL7 messages (NAACCR, 2011). 
 
The second casefinding source is the ICD-9 list (disease indices). Unlike 
pathology reports, index codes have much less information, because they display code 
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without further information on how or why the case was coded in such a way. To confirm 
the diagnosis, registrars often need to cross-reference the disease indices with additional 
sources, including pathology reports, surgery reports, and/or oncology records. In this 
proposed workflow, cases that are identified as reportable by pathology reports and have 
codes associated with them will distinguish them from others. If the information collected 
from the pathology report is sufficient to confirm the case as reportable, that case will be 
ready for abstracting and further review, since index codes will not be needed. Index 
codes can also be matched with previously reported cases to help distinguish new cases 
from recurrent ones. Such functions can be made available in some commercial oncology 
management systems.  
 
 Notification Systems 
 
After the case is identified at the casefinding stage, it is stored in a suspense file. 
Generally, cases reside in the suspense file for a few months, as treatments and 
procedures are performed and entered into the EHR system. However, procedures and 
treatments can be done at different speeds, depending on factors, such as the cancer type, 
stage, and facility resources, among others. Using a standard waiting time for all cases 
can create an unnecessary delay if treatments are made available earlier than expected.  
 
In the proposed workflow, we recommend a communication system between the 
local oncology management system and the EHR to determine when to start abstracting. 
A notification system will alert the reporting registrar when new treatments are available 
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in the EHR for any cases in the suspense file. Using a notification system, registrars will 
be able to abstract the case as soon as treatment is available. If a patient receives no 
treatment within 6 months from the date of the casefinding, then the registrar can start 
abstracting. The unavailability of treatment in medical records may be due to 
possibilities, including receiving treatment at an external facility, refusing treatment, or 
death.  
 
Leveraging the health information infrastructure for cancer reporting can 
positively affect the workflow. The use of notification systems for workflow optimization 
has been noted in other healthcare areas, such as care coordination (Moore et al., 2012). 
System notification can be implemented using Health Level Seven (HL7) Clinical 
Document Architecture (CDA) notification messages. Once a new treatment is added to 
the EHR, the notification system will match it with patient lists in the suspense file. If a 
match is found, registrars will be notified of the new treatment (see Figure 4-36). Some 
CDA specifications can be found at the CDC Implementation Guide for Ambulatory 
Healthcare Provider Reporting to Central Cancer Registries, Release 1.0 (CDC, 2014). 
 
 Access to Health Information Exchanges (HIEs) 
 
Access to external records was one of the biggest barriers that registrars 
encountered. Using some of the existing health information exchange systems to facilitate 
access to information can minimize many obstacles. Studies have shown the benefits of 
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HIEs for improving access to clinical data (Fontaine, Ross, Zink, & Schilling, 2010). 
Several states already have the HIE infrastructure to address this gap. 
 
Especially in Indiana, the ISDH should explore the benefits of the Indiana 
Network for Patient Care (INPC) to address some cancer registry challenges. INPC 
includes a large portion of the medical records needed for cancer reporting, such as 
laboratory, radiology, and dictation. It covers 25,000 physicians, 106 hospitals, and 110 
clinics and surgery centers within the State of Indiana (Indiana Health Information 
Exchange).  
 
Moreover, the INPC presents the opportunity for automating the identification 
and detection of cancer, which is especially useful for monitoring and surveillance. Most 
cancer cases are diagnosed through laboratory histology. Many studies document the 
feasibility of automatic cancer identification and detection through pathology reports 
(Hanauer, Miela, Chinnaiyan, Chang, & Blayney, 2007; Kasthurirathne et al., 2016; 
Kavuluru, Hands, Durbin, & Witt, 2013). As the study by Kasthurirathne et al. (2016) 
showed, the automatic information extraction of pathology reports is a feasible and 
practical approach. The study also suggested that this approach could be generalized to 
other clinical data (Kasthurirathne et al., 2016).  
 
In addition to cancer monitoring and surveillance, INPC can support a wide range 
of cancer research activities. Within the State of Indiana, the Regenstrief Medical Record 
System (RMRS) and INPC have previously provided data needed in diverse research 
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activities and domains (Dixon, Whipple, Lajiness, & Murray, 2015). Research activities 
include observational studies, health services research, and comparative effectiveness 
research (Dixon, Whipple, et al., 2015).  
 
 Secure Messaging Systems 
 
Results show that some registrars encounter difficulties when asking clinicians for 
patient information at external facilities; because of this, they then contact registrars at 
external facilities in order to access patient information. This was perceived as more 
efficient in terms of accessing the information needed, given that registrars’ understand 
each other’s job roles and reporting requirements. In this workflow model, we propose 
usage of a secure messaging system to facilitate communication among registrars and to 
minimize the access barrier. Studies have shown that use of secure messaging systems in 
other clinical settings improves communication effectiveness among health professionals 
(Joos, Chen, Jirjis, & Johnson, 2006).  
 
 Potential for Improvement 
 
Simulation was applied to estimate improvements in reporting speed. The 
redesigned workflow is expected to reduce reporting time from an average of 138 days to 
51 days (Tables 4-7). This is based on the simulated assumption of time that cases reside 
in the suspense file (Figure 4-14). Despite barriers to the current reporting process, 
analyses show that cases spend the most time in the suspense file as registrars wait for 
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treatment data to become available. Even though registrars tend to agree that the time 
patients wait for treatment can vary among cancer types or patients with the same types 
of cancer, abstracting cases from the suspense file is performed in a chronological order 
that uses the FIFO (first-in, first-out) queuing system. By applying FIFO, the average 
wait time needed is more likely to be determined by the time needed for cases with higher 
waiting times so as to avoid early abstracting. We should note that early abstracting will 
increase the workload, as registrars may have to search, wait, and search again if 
treatment has not become available.  
 
5.5.2  National Based (Centralized) Workflow 
 
This section provides a brief workflow overview that describes a vision for a 
cancer reporting system. In this visionary workflow, some of the health information 
technologies will be incorporated into data transmission and retrieval. 
 
As seen in the Results Chapter, the current process has many challenges that 
prevent timely reporting. Common challenges, such as access barriers and lengthy 
searching and retrieval times, cannot be simply eliminated by adding staff or increasing 
working hours. Reducing reporting time will require changing the current structure and 
workflow practice to facilitate data sharing and access to information. To reduce 
reporting time, we suggest shifting to centralized reporting. We also suggest leveraging 
some of the public health information exchange techniques for information transfer and 
case identification. 
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The most common barrier that was identified during the interview was access to 
external records. When patients transfer from one facility to another, registrars from both 
facilities are responsible for finding and retrieving the information from external records, 
which often entails many challenges, including identifying the facility to which the 
patient was transferred and then seeking access to the relevant records. When this occurs, 
registrars from both facilities must create abstracts and reports that result in an increased 
workload. Centralizing the workflow can eliminate many access barriers and duplicate 
reporting. 
  
 Meaningful Use and Public Health Reporting 
 
The increased use of certified EHR and the requirements for Meaningful Use 
(MU) compliance present an opportunity for transforming the traditional cancer case 
reporting workflow into a centralized model. Recently, there has been significant 
emphasis on the implementation and use of certified EHRs, those which comply with 
regulations stipulated in the MU incentive program (HHS, 2015). Eligible hospitals and 
providers are implementing certified EHRs in record numbers (Adler-Milstein et al., 
2015; CMS, 2015). The number of U.S. hospitals adopting the basic EHR systems grew 
from 59% in 2013 to 75% in 2015 (Adler-Milstein et al., 2015). The increase in EHRs’ 
implementation is often accompanied with adherence to MU criteria. Studies shows that 
the number of hospitals meeting the core stage 2 MU criteria increased from 5.8% in 
2013, to reaching 40.5% in 2015 (Adler-Milstein et al., 2015).  
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The increasing adoption of certified EHRs and MU compliance facilitated the 
utilization of public health reporting. Studies have documented the positive association 
between informatics capabilities and public health service provision, especially with 
services targeting population health (Mac McCullough & Goodin, 2014). More hospitals 
are participating in immunizations, syndromic surveillance, and reportable infectious 
disease electronic reporting every year (Health IT Dashboard, 2014). In addition to 
surveillance activities, studies within the U.S. are shifting toward population health 
application at the state and local levels (Dixon, Pina, Kharrazi, Gharghabi, & Richards, 
2015). Most of the population health application and activities depend on the EHR 
capability of data collection and transmission. Since most systems cannot communicate 
effectively, HIE was introduced to function as the middle layer and facilitate the 
exchange of data (Finnell & Dixon, 2015).  
 
One of the biggest concerns in HIE is data interoperability and standards. 
However, with the increasing implementation and use of EHRs, health information 
technology innovation and interoperability solutions are expected to advance (Sheikh, 
Sood, & Bates, 2015). The adoption of health exchanges and interoperability standards 
was also promoted by CMS incentives. MU stage 2 requires hospitals and healthcare 
providers to incorporate Clinical Document Architecture (CDA) for information 
exchange. CDA is a common HL7 standard for specifying the encoding, structure, and 
semantics of clinical documents for exchange. One of the most appropriate CDA 
documents for sharing detailed patient information with public health entities is the 
Continuity of Care Document (CCD) (Health IT, 2013). CCD suits this purpose, as it is 
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source-independent and enables the exchange of demographic data that is necessary for 
matching and clinical data (D’Amore, Sittig, & Ness, 2012). A simplified example of a 
CCD format can be seen in Figure 5-1 (D’Amore et al., 2012). 
 
 
Figure 5-1: A simplified example of a CCD structure. Source: D’Amore, Sittig, & Ness. 
“How the Continuity of Care Document Can Advance Medical Research and Public 
Health.” American Journal of Public Health 102.5 (2012): E1–E4. 
 
 Workflow Description 
 
The recommended workflow is based on a centralized approach in which most of the 
processing is performed at the central registry, rather than by the reporting hospitals. The 
workflow steps are described below. 
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 Data Transfer 
 
In this workflow, patients’ records are transferred to the central registry for 
processing. The transfer of patient information can be accomplished using CCD. 
Triggering events can be created for automatic detection and transfer of cancer-related 
information. A key component of CCD transmission is the specification of identified data 
elements, vocabularies, and other requirements. One of the established efforts with regard 
to the cancer registry data elements is the CDA Implementation Guide for Ambulatory 
Healthcare Provider Reporting to Central Cancer Registries (HL7 International). 
 
 Records Matching  
 
Records transferred from each facility will then be matched at the patient level at 
the central registry. This minimizes the need for duplicate abstracting, if patients receive 
care at more than one facility, as well as provides more complete and comprehensive 
records.  
 
At this phase, we should mention some of the challenges associated with records 
matching, which includes the lack of unique patients’ identifier. Currently, EHRs work 
solo, where each hospital creates a Medical Records Number (MRN) for its patients. 
Since the MRN differs in each hospital, it cannot be used for records matching. 
Currently, the U.S. does not have unique patient identifiers that could be employed for 
matching medical records (McFarlane, Dixon, & Grannis, 2016).  
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One of the most commonly used techniques to overcome this challenge is known 
as probabilistic matching. In probabilistic matching, a set of demographic attributes, 
including name, date of birth, address, and/or Social Security number are being used 
instead of a single records number. One of the advantages to probabilistic matching is 
flexibility in working with incomplete information and errors. Instead of determining 
whether or not the demographic attributes are an exact match, it assigns a score based on 
the degree of matching. A higher score indicates more confidence that the records being 
matched represent the same patient. With probabilistic matching, a cutoff score is often 
assigned to determine if the records being compared will be accepted as a true match. 
Achieving a higher score will require more complete and accurate data from all sources. 
Therefore, is important to encourage the collection of more complete, accurate, and up-
to-date demographic data (McFarlane et al., 2016). 
 
 Case Finding 
 
E-path will still be used as the main case finding tool, due to its high sensitivity 
and the large percentage of cancer cases that are diagnosed through pathology reports. 
The second data source for case finding will be the ICD codes (indices codes). In this 
workflow, the ICD codes will be matched with other patients’ diagnostic reports that are 
retrieved through CCD. Unlike ICD codes, diagnostic reports can provide more detailed 
information about the cases, which will provide a clearer and more comprehensive view 
by combining patient information from multiple sources, thus making it easier to 
determine case eligibility for reporting and saving some of the time spent on information 
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search and retrieval. This will make the demographics, tumor type, and stage available 
sooner for rapid case ascertainment without the need to wait for treatment data.  
 
 Abstracting  
 
Most of the data related to demographics, cancer type, and stage, can be collected 
at the casefinding stage. For the complete abstract, treatment and procedure data is often 
necessary. By utilizing the event triggers for treatment data, registrars will be notified 
about the availability of new treatments for any case identified at the casefinding stage. 
This will involve matching the received CCD with the cases that are identified at the 
case-finding stage. Once the abstract is completed, the records can be added to the central 
registry. By adding records as soon as they are completed, we can eliminate the waiting 
period between the record submission time and record completion time. 
 
5.6 Study Contribution 
 
System design and planning, data collection, and data management are essential 
aspects of health informatics (Savel & Foldy, 2012). The study of data production and 
sharing serve as fundamental components of health informatics’ research, and are 
consistently applied to create solutions that support healthcare delivery and research 
(American Medical Informatics Association, 2015). Particularly in cancer, the timeliness 
of registry data is critical for the discovery and improvement in quality of care (Centers 
for Disease Control and Prevention, 1999; Simone & Hewitt, 2000).  
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The significance of timeliness in cancer registry data is documented in several 
IOM and CDC reports (Centers for Disease Control and Prevention, 1999; Simone & 
Hewitt, 2000). Few studies in Europe have evaluated the timeliness of cancer registry 
data. In the U.S., a study by Gagen and Cress (2005) investigated some of the factors 
associated with reporting delays by examining the association between reporting delays 
and gender, race, type of facility, cancer site, and/or stage at diagnosis (Smith-Gagen et 
al., 2005). However, the studies found evaluated timeliness as part of the DQ evaluation. 
To the best of our knowledge, no previous studies have specifically investigated the 
efficiency of the cancer reporting process or the steps involved. The method described in 
this paper provides a systematic evaluation of data timeliness and the reporting process 
that can identify challenges and therefore contributes to our understanding and 
improvement of cancer reporting systems. Some of the key findings are presented in the 
following sections.  
 
The proposed method reveals variations among facilities in terms of both 
reporting time and the time completed cases reside at the facility database before they are 
reported to the state registry. This was found to be the case at 7 of the 22 facilities with 
higher caseloads. The 22 facilities classified as higher-caseload facilities account for 
90.5% of the total number of cases. The 7 identified facilities were found to take twice 
the amount of time to submit the completed records, compared with the remaining 15 
(around 100–300 days). The potential impact for improving timeliness in cancer reporting 
can be demonstrated by understanding the timeliness requirements of cancer registry 
standards. As seen in the previous sections, variations in timeliness requirements among 
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cancer registry standards are small. For example, the difference in timeliness 
requirements between the gold NAACCR certification and the silver NAACCR 
certification is 5% (NAACCR gold certification requires 95% of cases reported within 23 
months and silver certification requires 90% within 23 months). Moving from silver to 
gold certification, for instance, requires focusing on the 5% of cases that take more than 
23 months. During the registrar interview, the process of submitting completed reports 
was often described as fast and easy. Therefore, encouraging more frequent report 
submission could be a practical step to improving timeliness without investing in 
additional technology or staff. 
 
This study also shows that access to information can be the biggest barrier 
encountered by registrars. The interview results suggest that directing research and 
development into addressing these challenges could have a significant impact on the 
reporting process. Many states already have the HIE infrastructure that could be used to 
address this gap (Fontaine et al., 2010). 
 
More importantly, the results show that time spent on cancer reporting comprises 
not only task time but also waiting time, which consumes most of the overall reporting 
time. Most of this waiting time occurs while patients await treatments and procedures. 
Our findings suggest that this time can be significantly reduced by changing the currently 
followed queing method. Generally, cases reside in the suspense file for a few months, 
during which time treatments and procedures are performed and are entered into the EHR 
system. Thus, the first case entered into the suspense file will be the first case abstracted. 
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However, procedures and treatments can be done at different speeds, depending on 
factors such as the cancer type, cancer stage, and facility resources. Using a standard 
waiting time for all cases creates an unnecessary delay if treatments are made available 
earlier than prior cases. Adding a notification system to inform registrars of when 
treatments are available will enable them to abstract the case as soon as the treatment is 
available, instead of using a fixed period of time for all cases. 
 
5.7 Implications 
 
This study has implications in the following areas: systems design and development, 
quality management, and decision-making. Examples of the study implication are listed 
below. 
 
Phase 3 of the study has implications for systems engineering, design, and 
development. Informing systems engineers and designers of the barriers encountered by 
users and the time spent at each step can assist them in creating systems that meet 
information and work needs (McNulty & Ferlie, 2002). For example, in Phase 3, we 
found that casefinding from ICD is often time-consuming. Some systems enable 
registrars to match the ICD list with previously reported cases, a function that was found 
to be valuable for registrars. By understanding how the ICD list is interpreted by 
registrars, we could then recommend matching the ICD list with path reports and other 
sources used during the casefinding stage.  
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This study also informs system developers and hospital administrators about the 
privacy policy related to cancer reporting. Some examples are listed below. 
 
System session timeout is set as a safeguard measure for data protection. In Phase 
3, however, we see that session timeout is often perceived as a barrier by registrars. The 
time set for the session timeout is often estimated based on the average user’s activities. It 
sets the session expiration period to automatically log users out when they are away from 
the computer. With cancer reporting, however, registrars are multi-tasking, logging into 
more than one system, or making phone calls in search of information. Understanding the 
needs of registrars and the nature of their workflow can assist system developers and 
administrators in setting the appropriate privacy and security guidelines.  
 
Phase 3 also shows that many registrars experience some difficulty while 
accessing information within facilities outside the hospital network. When electronic 
access is not available, registrars use other methods—such as phone calls—to contact 
outside facilities. Some registrars have indicated that inquiring about patient information 
via the phone can be difficult when nurses and physicians are unwilling to share patient 
information due to their concerns about the privacy of patient information. Educating 
other health professionals, such as nurses and physicians, about the role of cancer 
registrars, can promote communication between them.  
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5.8 Limitations 
 
One of the limitations of Phase 2 was the high rate of missing data in one of the 
time intervals. The report completion phase consisted of case finding and abstracting. 
Separating the casefinding from the abstracting time requires the availability of “abstract 
initiation” dates. However, due to the high rate of missing data in the “abstract initiation” 
date, making the distinction between casefinding and abstracting was not possible. 
Instead, we calculated the combined time for report completion time. 
 
The second limitation is the time span from which the study data has been 
retrieved. This study retrieved cases diagnosed from 2000 to 2010. Considering the 
declining trend observed in reporting time and changes in heath technologies since 2010, 
our results may not reflect the current situation. 
 
A third limitation was the absence of filed observations in Phase 3. Data was 
collected in this study through interviews, and one of the advantages of the interview is 
the ability to capture the entire cycle of the process. This approach was appropriate for 
this study, because the entire reporting cycle can take months or years. However, similar 
to other self-reported techniques, interviews are subjected to self-reporting bias.  
 
A fourth limitation was estimating the simulation input for the redesigned 
workflow. To conduct the simulation for the redesigned workflow, we needed an 
estimation of the expected time cases reside in the suspense file. This is represented by 
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the time from casefinding to availability of treatment results. Registrars indicated that 
abstracting could commence at the beginning of the first course of treatment. To estimate 
the time, we used a national study that measures the time from diagnosis to treatment. As 
this could underestimate the simulation input by disregarding the time needed to write the 
treatment result and add it to the EHR, it may also overestimate it by disregarding the 
time from diagnosis to casefinding.  
 
Moreover, we should also recognize the tradeoff between completeness, accuracy, 
and timeliness when interpreting the simulation results. As stated above, registrars can 
currently abstract by the beginning of the first course of treatment. As the results of our 
simulation were estimated based on this scenario, they would not reflect situations 
wherein registrars decided to wait to add further data. The need to wait for more data was 
either to provide more complete abstracts or to confirm case diagnoses. In situations 
where the available data was insufficient to confirm the diagnosis, registrars might want 
to wait for more information to reach a higher degree of certainty. 
 
5.9 Future Work 
  
The results of this study point to the value of examining the time taken from 
diagnosis to treatment to set realistic expectations in terms of timeliness. Although 
different cancer standards require hospitals to report their cancer cases within a specific 
time period after diagnosis, registrars need to wait for treatments and procedures to be 
performed and are entered into the EHR. Knowing the expected time for the required 
 126 
information being ready in the EHR can help to determine the reasonable timeliness 
expectation for each cancer type.  
 
Another area to investigate is the relative importance of different information with 
respect to time. This study provided an indication of the time needed for casefinding and 
abstracting and informed us of the time needed to collect demographic information, 
cancer type, and cancer stage compared with the time needed to collect treatment 
information. Given the long period of time between casefinding and abstracting, we have 
found that information collected during casefinding (demographic information, cancer 
type, and cancer stage) can potentially be available much sooner, if reported separately. A 
similar technique was applied by the CoC for breast and colorectal cancer (American 
College of Surgeons, 2015). Knowing what the data will be used for and what 
information will be more valuable, if received sooner, can determine if a two-stage 
reporting process is needed to accelerate the timelines of this information. 
 
Future work may also include development and testing of the notification system. 
The role of the recommended notification system is to inform the abstracting registrars 
when new cancer treatment is available. A fundamental requirement for developing such 
a system is identifying the treatments and procedures to be included, as well as the 
corresponding specification for HL7 messages. The same will apply for enabling 
automatic public health reporting through the CDA. An established effort was made by 
the CDC to guide implementation of automatic reporting in EHRs and public health 
registries through CDA (HL7 International). 
 127 
 APPENDICES.  CHAPTER 6:
 
6.1 Interview script 
 
1. Demographic 
• Are you a CTR or a non-CTR?  
o Describe your role in reporting? 
 
2.Workload questions 
• Can you estimate the number of cases processed (daily or weekly)? 
• How many people in your workplace are involved in reporting? 
o How many of them are CTR and how many are not?  
o Do they perform the same task at the same time? 
o Do they share some of the resources, such as computers or phones? Is 
it enough? 
 
2. Process workflow questions  
• In order, what are the main steps for reporting? 
• How does reporting start (what triggers the event to start)? 
o Potential Probes; Are there other ways to initiate the process? 
This part can be repeated for the main steps: Case finding, abstracting, 
reporting, follow-up. 
 
 128 
• Describe the ______ process? 
! Potential Probes: What is the goal of this step? 
! Probes (casefinding): Are there cases/cancer types that take 
longer than others to find/identify? If yes, what are they? 
Why? 
! Probes (case finding): Do you work on an electronic or paper 
format? 
! Probes (abstracting): Are there certain types of information 
that take longer than other to abstract? If yes, how often do 
you have them? 
o Can you estimate the time it takes you to perform this step (daily or 
weekly) (range and average)? 
o At which point do you spend most of your time, and why? 
o Can you estimate the time you spend on this part? 
 
Repeat for abstracting, reporting, follow-up. 
 
• How do you know when a process is complete?  
o Are there any other possible outcomes? If yes, please describe? 
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4.Efficiency Questions 
• How often you encounter a delay or wait in the reporting process? If often:  
Potential probes: 
o Where in the reporting cycle does the delay exist?  
o What could happen? 
o Why would it happen?  
o How bad is it?  
o And when it happens, what you do about it? Is it effective? 
• Are there any parts of the reporting process you wish you could eliminate or fix? 
If yes,  
o Which part is it? 
• Why? Is there a time when you have to start over or repeat work? If yes, 
o How often? And, if often, 
! When (at what part), and why?  
5. Other 
• Regardless of the current constraints and limitations, what would the ideal 
reporting system look like? 
 
• Any other comments you would like to add? 
 
 130 
6.2 Reporting Frequency  
 
 Frequency of Report Submissions 
 
Figure A-1 (Facility #1): The frequency of report submissions. 
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Figure A-2 (Facility #6): The frequency of report submissions. 
 
Figure A-3 (Facility #11): The frequency of report submissions. 
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Figure A-4 (Facility #12): The frequency of report submissions. 
 
Figure A-5 (Facility #19): The frequency of report submissions. 
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Figure A-6 (Facility #20): The frequency of report submissions. 
 
Figure A-7 (Facility #21): The frequency of report submissions. 
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 Frequency of Reports Completions 
 
Figure B-1 (Facility #1): The frequency of report completions. 
 
Figure B-2 (Facility #6): The frequency of report completions. 
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Figure B-3 (Facility #11): The frequency of report completions. 
 
Figure B-4 (Facility #12): The frequency of report completions. 
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Figure B-5 (Facility #19): The frequency of report completions. 
 
Figure B-6 (Facility #20): The frequency of report completions. 
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Figure B-7 (Facility #21): The frequency of report completions. 
 
Frequency of cases diagnosed 
 
Figure C-1 (Facility #1): The frequency of cases diagnosed. 
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Figure C-2 (Facility #6): The frequency of cases diagnosed. 
 
Figure C-3 (Facility #11): The frequency of cases diagnosed. 
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Figure C-4 (Facility #12): The frequency of cases diagnosed. 
 
Figure C-5 (Facility #19): The frequency of cases diagnosed. 
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Figure C-6 (Facility #20): The frequency of cases diagnosed. 
 
Figure C-7 (Facility #21): The frequency of cases diagnosed. 
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6.3 Data sources used at the reporting process 
 
Data sources for case finding: 
• Pathology reports 
• Indices code 
• Admission and discharge reports 
• Surgery schedules 
• Cytology reports 
• Radiation oncology logs 
• Billing information 
• X-ray reports 
• Medical oncology  
• Radiation oncology reports 
• Chemotherapy 
 
Data sources for abstracting: 
• Pathology reports  
• Radiation oncology  
• Medical oncology 
• Physician notes 
• Oncology notes 
• Chemotherapy reports 
• Medical imaging 
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• Cytopathology reports 
• Surgery and operative reports 
• Treatments reports (such as hormones, biological response, or chemo). 
• Discharge summaries 
• Laboratory results 
• Consultation reports 
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